publication_id,tool,quote,best_match_source,best_match,similarity
1528,PRECIS-2,"Participants were included who scored >2 on the General Health Questionnaire 12, a measure of psychological distress, or >7 on the anxiety and depression subscales of the Hospital Anxiety and Depression Scale, thus confirming they had low mood.",fulltext,"participants were included who scored >2 on the General Health Questionnaire 12, 7 a measure of psychological distress, or >7 on the anxiety and depression subscales of the Hospital Anxiety and Depression Scale, 8 thus confirming they had low mood.",100.0
1528,PRECIS-2,Participants allocated to the control group received all other rehabilitation routinely provided and were offered the opportunity to attend groups once they had completed the study.,fulltext,Participants allocated to the control group received all other rehabilitation routinely provided and were offered the opportunity to attend groups once they had completed the study.,100.0
1528,PRECIS-2,"Four and eight months after random allocation, participants were sent a booklet of outcome questionnaires to complete and return by post.",fulltext,"Four and eight months after random allocation, participants were sent a booklet of outcome questionnaires to complete and return by post.",100.0
1528,PRECIS-2,The analysis was conducted from the perspective of the UK National Health Service (NHS).,fulltext,The analysis was conducted from the perspective of the UK National Health Service (NHS).,100.0
1528,PRECIS-2,"The main measures were outcomes assessed four and eight months after randomization, blind to group allocation.",fulltext," Main measures: Outcomes were assessed four and eight months after randomization, blind to group allocation.",93.63636363636364
1528,PRECIS-2,The details of this study have been published elsewhere.,fulltext,The details of this study have been published elsewhere.,100.0
1528,PRECIS-2,The groups involved teaching people to recognise symptoms of distress and introduced them to strategies to improve their mood.,fulltext,The groups involved teaching people to recognise symptoms of distress and introduced them to strategies to improve their mood.,100.0
1528,PRECIS-2,"The groups were delivered by two Band 5 assistant psychologists, who were supervised by a Band 8a clinical psychologist, experienced in working with people with multiple sclerosis.",fulltext,"The groups were delivered by two Band 5 assistant psychologists, who were supervised by a Band 8a clinical psychologist, experienced in working with people with multiple sclerosis.",100.0
1528,PRECIS-2,Participants were recruited for a randomized trial of adjustment groups for people with multiple sclerosis and low mood between June 2008 and September 2009.,fulltext,Participants were recruited for a randomized trial of adjustment groups for people with multiple sclerosis and low mood between June 2008 and September 2009.,100.0
1529,PRECIS-2,"Because the patients were not hospitalized and regularly referred to the Association, to follow randomized assignment, we decided to run the sampling within two consecutive months until we enrolled an adequate number of participants.",fulltext,"Because the patients were not hospitalized and regularly referred to the Association, to follow randomized assignment, we decided to run the sampling within two consecutive months until we enrolled an adequate number of participants.",100.0
1529,PRECIS-2,The study population consists the patients referring to the Multiple Sclerosis Society of Isfahan.,fulltext,The study population consists the patients referring to the Multiple Sclerosis Society of Isfahan.,100.0
1529,PRECIS-2,"At completion of the training program, all happy techniques were briefly reviewed with the participants, the participants were asked some questions about their current happiness and optimism levels, and their questions, if any, were answered.",fulltext,"At completion of the training program, all happy techniques were briefly reviewed with the participants, the participants were asked some questions about their current happiness and optimism levels, and their questions, if any, were answered.",100.0
1529,PRECIS-2,"This study was conducted to investigate the effect of Fordyce Happiness Model (FHM) on depression, stress, anxiety, and fatigue in MS patients.",fulltext,"This study was conducted to investigate the effect of Fordyce Happiness Model (FHM) on depression, stress, anxiety, and fatigue in MS patients.",100.0
1529,PRECIS-2,"The inclusion criteria were being definitely diagnosed with MS and having records in the Society and the exclusion criteria having history of other psychiatric disorders including major depressive disorder (according to the medical records and the physician's examinations) or bipolar disorder (except for cognitive disorders by which MS is characterized), substance dependency, any neurological disorders, history of taking corticosteroids or the disease recurrence within the previous six months.",fulltext,"The inclusion criteria were being definitely diagnosed with MS and having records in the Society and the exclusion criteria having history of other psychiatric disorders including major depressive disorder (according to the medical records and the physician's examinations) or bipolar disorder (except for cognitive disorders by which MS is characterized), substance dependency, any neurological disorders, history of taking corticosteroids or the disease recurrence within the previous six months.",100.0
1529,PRECIS-2,This clinical trial was conducted in 2015-2016 and registered as IRCT2014112420064N1 in the Iranian Register of Clinical Trials.,fulltext,This clinical trial was conducted in 2015e2016 and registered as IRCT2014112420064N1 in the Iranian Register of Clinical Trials.,99.21875
1529,PRECIS-2,"The intervention was implemented within two days a week. For the control group, a routine protocol was conducted.",fulltext,"The intervention was implemented within two days a week. For the control group, a routine protocol was conducted.",100.0
1529,PRECIS-2,"The intervention consisted of: defining depression, stress, anxiety, and their symptoms, defining happiness, and explaining its necessity, reviewing the results of previous studies on happiness (the first session); the technique of increasing physical activity, the technique of being productive, and doing useful and meaningful things (the second session); the principles of planning and better organization–the technique of removing concerns, the technique of reducing expectations and wishes (the third session); the technique of enhancing creativity, the technique of living at present (the fourth session); the technique of increasing social relationships, the technique of being the real self (the fifth session).",fulltext,"The intervention consisted of: defining depression, stress, anxiety, and their symptoms, defining happiness, and explaining its necessity, reviewing the results of previous studies on happiness (the first session); the technique of increasing physical activity, the technique of being productive, and doing useful and meaningful things (the second session); the principles of planning and better organization–the technique of removing concerns, the technique of reducing expectations and wishes (the third session); the technique of enhancing creativity, the technique of living at present (the F. Khayeri et al. / Complementary Therapies in Clinical Practice 25 (2016) 130e135 131 fourth session; the technique of increasing social relationships, the technique of being the real self (the fifth session).",99.86091794158554
1529,PRECIS-2,The data were analyzed by SPSS 18.,fulltext,The data were analyzed by SPSS 18.,100.0
1529,PRECIS-2,"Moreover, to investigate the efficacy of the FHM, the DASS-21 and Piper Standard Scale were administered to the experimental group in the follow-up session.",fulltext,"Moreover, to investigate the efficacy of the FHM, the DASS-21 and Piper Standard Scale were administered to the experimental group in the follow-up session.",100.0
1567,PRECIS-2,The project staff used a script to screen potential participants and explain the study requirements to those who called the toll-free number and met eligibility criteria.,fulltext,The project staff used a script to screen potential participants and explain the study requirements to those who called the toll-free number and met eligibility criteria.,100.0
1567,PRECIS-2,The intervention included group sessions (2 h per week for 8 weeks) focused on building efficacy for use of cognitive strategies and a home-based computer training program (45 min three times per week).,fulltext,The intervention includes group sessions (2 h per week for 8 weeks) focused on building efficacy for use of cognitive strategies and a home-based computer training program (45 min three times per week).,99.5049504950495
1567,PRECIS-2,"Although individuals varied their computer training time from week to week, 68% met or exceeded the total time prescribed over the 8-week intervention.",fulltext,"Although individuals varied their computer training time from week to week, 68% met or exceeded the total time prescribed over the 8-week intervention.",100.0
1567,PRECIS-2,"The primary purpose of this study was to determine the effectiveness of a novel computer-assisted cognitive rehabilitation intervention MAPSS-MS (Memory, Attention, Problem Solving Skills in MS) in a multi-site trial with persons with MS.",fulltext,"The primary purpose of this study was to determine the effectiveness of a novel computerassisted cognitive rehabilitation intervention MAPSS-MS (Memory, Attention, Problem Solving Skills in MS) in a multi-site trial with persons with MS.",99.57983193277312
1567,PRECIS-2,"Changes in study outcomes were analyzed using intention to treat methodology, ANOVA with repeated measures, and ANCOVA.",fulltext,"Changes in study outcomes were analyzed using intention to treat methodology, ANOVA with repeated measures, and ANCOVA.",100.0
1567,PRECIS-2,The computer component enabled participants (N = 63) to engage in practice sessions without leaving their homes.,fulltext,The computer component enabled participants (N ¼ 63) to engage in practice sessions without leaving their homes.,99.10714285714286
1567,PRECIS-2,Persons with MS (N = 183) with cognitive concerns were randomly assigned to either the 8-week MAPSS-MS intervention or usual care plus freely available computer games.,fulltext,Persons with MS (N ¼ 183) with cognitive concerns were randomly assigned to either the 8week MAPSS-MS intervention or usual care plus freely available computer games.,98.80239520958084
1567,PRECIS-2,"Neuropsychological testing and questionnaire data were collected from all subjects at baseline, following completion of the intervention, and 3 and 6 months post-intervention.",fulltext,"Neuropsychological testing and questionnaire data were collected from all subjects at baseline, following completion of the intervention, and 3 and 6 months post-intervention.",100.0
1567,PRECIS-2,"Participants were recruited via physician referral, targeted mailings to persons with MS on the mailing list of the National MS Society, contact with support groups, and notices in MS newsletters and web sites.",fulltext,"Participants were recruited via physician referral, targeted mailings to persons with MS on the mailing list of the National MS Society, contact with support groups, and notices in MS newsletters and web sites.",100.0
1568,PRECIS-2,The exercise intervention included 3892 minutes of aerobic exercise at an average intensity of 76.2% HRmax. The exercise sessions consisted of continuous sessions lasting 30–60 minutes with an intensity of 60%–80% HRmax and interval training sessions lasting 30–60 minutes with an interval duration of 1–10 minutes and intensities varying from 65%–95% HRmax.,fulltext,the exercise intervention included 3892 minutes of aerobic exercise at an average intensity of 76.2% HRmax. The exercise sessions consisted of continuous sessions lasting 30–60 minutes with an intensity of 60%–80% HRmax and interval training sessions lasting 30–60 minutes with an interval duration of 1–10 minutes and intensities varying from 65%–95% HRma,99.4413407821229
1568,PRECIS-2,"All patients were scanned using the exact same 3-Tesla MRI scanner (MAGNETOM Skyra, Siemens Medical Systems, Erlangen, Germany) at the same location, for all patients, and at all timepoints.",fulltext,"All patients were scanned using the exact same 3-Tesla MRI scanner (MAGNETOM Skyra, Siemens Medical Systems, Erlangen, Germany) at the same location, for all patients, and at all timepoints.",100.0
1568,PRECIS-2,"The supervised exercise sessions were performed twice weekly for the full study period of 48 weeks, and was planned on the basis of four principles (adapted from Stathopoulos and Felson Duchan) 13: (1) individual tailoring, (2) application of exercise types matching the goal of the intervention, (3) progressive overload and (4) sufficient intensity to induce the desired effects of the intervention.",fulltext,"The supervised exercise sessions were performed twice weekly for the full study period of 48 weeks, and was planned on the basis of four principles (adapted from Stathopoulos and Felson Duchan) 13 : (1) individual tailoring, (2) application of exercise types matching the goal of the intervention, (3) progressive overload and (4) sufficient intensity to induce the desired effects of the intervention.",100.0
1568,PRECIS-2,"Patients (n = 84) were recruited in collaboration with six Danish regional MS clinics and The Danish MS Society. Inclusion criteria were (1) 18–60 years of age, (2) ⩽2 years since clinical diagnosis with relapsing remitting MS (RRMS) and (3) no relapses or changes in medication status 8 weeks prior to inclusion.",fulltext,"Patients (n = 84) were recruited in collaboration with six Danish regional MS clinics and The Danish MS Society. Inclusion criteria were (1) 18–60 years of age, (2) ⩽2 years since clinical diagnosis with relapsing remitting MS (RRMS) and (3) no relapses or changes in medication status 8 weeks prior to inclusion.",100.0
1568,PRECIS-2,The relapse rate and the global brain atrophy rate were the primary outcomes of this study.,fulltext,The relapse rate and the global brain atrophy rate were the primary outcomes of this study.,100.0
1568,PRECIS-2,"Patients in the supervised exercise group completed 90.0 (8.6)% of the planned sessions at an average intensity of 84.4 (3.0)% HRmax (for comparison, the planned average intensity was 76.2% HRmax).",fulltext,"Patients in the supervised exercise group completed 90.0 (8.6)% of the planned sessions at an average intensity of 84.4 (3.0)% HRmax (for comparison, the planned average intensity was 76.2% HRmax).",100.0
1568,PRECIS-2,"The study period covers 48 weeks with outcome assessment at baseline (T0), after 24 weeks (T24), and after 48 weeks (T48).",fulltext,"The study period covers 48 weeks with outcome assessment at baseline (T0), after 24 weeks (T24), and after 48 weeks (T48).",100.0
1568,PRECIS-2,"A Poisson regression controlling for a priori defined potential confounding variables (age, gender and time since diagnosis) and expressed as an incidence-rate-ratio was applied to compare the annual relapse rate between the RCT groups.",fulltext,"A Poisson regression controlling for a priori defined potential confounding variables (age, gender and time since diagnosis) and expressed as an incidence-rate-ratio was applied to compare the annual relapse rate between the RCT groups.",100.0
1568,PRECIS-2,"Patients were randomized to the two study conditions by the sealed envelope principle in a 1:1 ratio stratified by line of treatment. Data from The Danish MS Registry served as a national population-based control group, in addition to the two RCT groups.",fulltext,"Patients were randomized to the two study conditions by the sealed envelope principle in a 1:1 ratio stratified by line of treatment. Data from The Danish MS Registry served as a national population-based control group, in addition to the two RCT groups.",100.0
1569,PRECIS-2,"Five patients in the TOCT group did not complete the 12-weeks home-based TOCT (1 due to MS worsening, 3 for personal issues, 1 discontinued the intervention).",fulltext,"Five patients in the TOCT group did not complete the 12-weeks home-based TOCT (1 due to MS worsening, 3 for personal issues, 1 discontinued the intervention).",100.0
1569,PRECIS-2,"An intention-to-treat analysis was carried out on all outcome measures, handling missing data (n = 2 at T1, n = 7 at T2) with the last observation carried forward approach.",fulltext,"An intention-to-treat analysis was carried out on all outcome measures, handling missing data (n = 2 at T1, n = 7 at T2) with the last observation carried forward approach.",100.0
1569,PRECIS-2,"The primary outcome measure was the 6-minute walking test (6MWT) for walking endurance (Goldman et al., 2008).",fulltext,"The primary outcome measure was the 6-minute walking test (6MWT) for walking endurance (Goldman et al., 2008).",100.0
1569,PRECIS-2,"The experimental group increased by 29.80 (42.55) m after Phase 1, with a further gain of 44.07 (55.35) m after Phase 2.",fulltext,"The experimental group increased by 29.80 (42.55) m after Phase 1, with a further gain of 44.07 (55.35) m after Phase 2.",100.0
1569,PRECIS-2," performed functional tests, questionnaires and instrumental measurements the week before treatment, the week after the end of the supervised-TOCT, after the 12-weeks home-based TOCT program.",fulltext,", performed functional tests, questionnaires and instrumental measurements the week before treatment, the week after the end of the supervised-TOCT, after the 12-weeks home-based TOCT program",99.47643979057592
1569,PRECIS-2,Treatment allocation occurred when the informed consent was obtained and baseline assessments were completed.,fulltext,Treatment allocation occurred when the informed consent was obtained and baseline assessments were completed.,100.0
1569,PRECIS-2,Allocation was concealed from the outcome assessor and the investigators involved in the patients’ enrolment.,fulltext,Allocation was concealed from the outcome assessor and the investigators involved in the patients’ enrolment.,100.0
1569,PRECIS-2,The Multiple Sclerosis Task-Oriented Circuit Training (MS_TOCT) trial is an assessor-blinded randomized controlled trial approved by the Ferrara Ethics Committee (registration number 140489) and registered on the ClinicalTrials.gov database (NCT02421744).,fulltext,The Multiple Sclerosis Task-Oriented Circuit Training (MS_TOCT) trial is an assessor-blinded randomized controlled trial approved by the Ferrara Ethics Committee (registration number 140489) and registered on the ClinicalTrials.gov database (NCT02421744).,100.0
1569,PRECIS-2,The blind evaluator ,fulltext,The blind evaluator ,100.0
1569,PRECIS-2,"The inclusion criteria were: males and females; age 18 to 70; diagnosis of MS (primary or secondary progressive, relapsing-remitting), without relapses in the preceding three months and an Expanded Disability Status Scale (EDSS) score between 4 and 5.5.",fulltext,"The inclusion criteria were: males and females; age 18 to 70; diagnosis of MS (primary or secondary progressive, relapsing-remitting), without relapses in the preceding three months and an Expanded Disability Status Scale (EDSS) score between 4 and 5.5.",100.0
1569,PRECIS-2,Patients have been recruited at Ferrara University Hospital from patients who attend the Rehabilitation Outpatient Clinic for gait rehabilitation.,fulltext,Patients have been recruited at Ferrara University Hospital from patients who attend the Rehabilitation Outpatient Clinic for gait rehabilitation.,100.0
1570,PRECIS-2,"For comparison of the primary and final EDSS in each group, the paired samples t.test, for comparison of the changes in the primary and final EDSS between the groups, the One-Way ANOVA test and for comparison of side effects between the three drugs, the Pearson- chi-square were used.",fulltext,"compared. For comparison of the primary and final EDSS in each group the paired samples t.test, for comparison of the changes in the primary and final EDSS between the groups, the One-Way ANOVA test and for comparison of side effects between the three drugs, the Pearson- chi-square ",96.12676056338029
1570,PRECIS-2,"The study was a randomized clinical trial and included all the patients with MS referring to the Farshchian Hospital, Hamadan (West Iran) during the year 2005-2006, who had the following criteria.",fulltext,"Methods The study was a randomized clinical trial and included all the patients with MS referring to the Farshchian Hospital, Hamadan (West Iran) during the year 20052006, who had the following c",95.40816326530613
1570,PRECIS-2,"The patients in all three groups were evaluated at the end of months 6, 12, 18, 24 and in case of development of reactions were excluded from the study.",fulltext,"The patients in all three groups were evaluated at the end of months 6, 12, 18, 24 and in case of development of reactions were excluded from the study.",100.0
1570,PRECIS-2,"The patients were divided into three equal groups: group 1 received Av, group 2 received Re and group 3 received Be, and after 24 months, comparison was done by calculating primary and final EDSS and the relapse rate.",fulltext,"The patients were divided into three equal groups: group 1 received Av, group 2 received Re and group 3 received Be, and after 24 months, comparison was done by calculating primary and final EDSS and the relapse rate.",100.0
1570,PRECIS-2,"According to the inclusion criteria the patients were treated as follows: 30 patients received Av (30 mcg IM on a weekly basis), 30 patients received Re (44 mcg SC three times a week) and 30 patients received Be (250 mcg SC on an alternate day basis).",fulltext,"According to the inclusion criteria the patients were treated as follows: 30 patients received Av (30 mcg IM on a weekly basis), 30 patients received Re (44 mcg SC three times a week) and 30 patients received Be (250 mcg SC on an alternate day basis).",100.0
1769,PRECIS-2,"The treated group were given corticotrophin (‘Acthar’ gel) in a dosage which varied between 15 and 25 units daily, potassium chloride orally, and a low-salt diet.",fulltext,"The treated group were given corticotrophin (’ Acthar ’ gel) in a dosage which varied between 15 and 25 units daily, potassium chloride orally, and a low-salt diet.",100.0
1769,PRECIS-2,Both treated and control groups were given aneurin 100 mg by injection monthly.,fulltext,Both treated and control groups were given aneurin 100 mg. by injection monthly.,100.0
1769,PRECIS-2,"Patients with multiple sclerosis were randomly selected into treated and control groups; only patients who could walk with or without walking aids were admitted to the trial, and these cases were initially assessed and scored during an inactive phase of the disease.",fulltext,"Patients with multiple sclerosis were randomly selected into treated and control groups; only patients who could walk with or without walking aids were admitted to the trial, and these cases were initially assessed and scored during an inactive phase of the disease.",100.0
1769,PRECIS-2,All cases were seen at three-monthly intervals and scored on the Kurtzke (1961) scale; relapses lasting longer than twenty-four hours were also scored by a system in the three centres.,fulltext,All cases were seen at three-monthly intervals and scored on the Kurtzke (1961) scale; relapses lasting longer than twenty-four hours were also scored by a system in the three centres.,100.0
1769,PRECIS-2,Altogether there were 181 treated patients and 169 control patients followed up for an average period of eighteen and a half months.,fulltext,Altogether there were 181 treated patients and 169 control patients followed up for an average period of eighteen and a half months.,100.0
1769,PRECIS-2,The dose of corticotrophin was adjusted to produce just enough ‘mooning’ of the face to be appreciated by the physician in charge of the trial and the dose was not increased during a relapse.,fulltext,"The dose of corticotrophin was adjusted to produce just enough "" mooning "" of the face to be appreciated by the physician in charge of the trial and the dose was not increased during a relapse.",100.0
1769,PRECIS-2,"There is no evidence to suggest that the treated group do better than the controls, either from the point of view of deterioration or reduction in number or severity of relapses.",fulltext,"There is no evidence to suggest that the treated group do better than the controls, either from the point of view of deterioration or reduction in number or severity of relapses.",100.0
1769,PRECIS-2,A separate trial was carried out in the three centres using the same treatment and scoring methods.,fulltext, separate trial was carried out in the three centres using the same treatment and scoring methods.,98.98989898989899
1769,PRECIS-2,"In Manchester, patients who had relapsed in the previous eighteen months only were admitted to the trial.",fulltext,"In Manchester, patients who had relapsed in the previous eighteen months only were admitted to the trial.",100.0
1769,PRECIS-2,"This controlled study was started in 1963 in three cities-Belfast, Leeds, and Manchester.",fulltext,"This controlled study was started in 1963 in three citiesBelfast, Leeds, and Manchester.",98.87640449438202
1770,PRECIS-2,"Patients were withdrawn from the study if other treatment with ACTH, corticosteroids or immunosuppressive drugs was started.",fulltext,"Patients were withdrawn from the study if other treatment with ACTH, corticosteroids or immunosuppressive drugs was started.",100.0
1770,PRECIS-2,"Only patients with a clinical or laboratory-supported definite diagnosis of MS according to the Poser criteria (6), suffering from a relapse, were included.",fulltext,"ported definite diagnosis of MS according to the Poser criteria (6), suffering from a relapse, were included.",69.87179487179486
1770,PRECIS-2,"Patients with contraindications to bed rest or ACTH-treatment, such as hypersensitivity to ACTH, acute infections, cardial insufficiency, psychosis, pregnancy, Cushing syndrome or peptic ulcer, were excluded.",fulltext,"Patients with contraindications to bed rest or ACTH-treatment, such as hypersensitivity to ACTH, acute infections, cardial insufficiency, psychosis, pregnancy, Cushing syndrome or peptic ulcer, were excluded.",100.0
1770,PRECIS-2,The major results are summarized in the Tables 2 and 3 and Fig. 1.,fulltext,The major results are summarized in the Tables 2 and 3 and Fig. 1.,100.0
1770,PRECIS-2,"Patients were allocated in a stratified randomisation to treatment with either bed rest during 3 weeks and a synthetic ACTH depot preparation (1 mg, 100 units, tapered over 12 weeks), and Vitamin B-complex or bed rest and Vitamin B-complex intramuscular injections in the same scheme (5).",fulltext,"Patients were allocated in a stratified randomisation to treatment with either bed rest during 3 weeks and a synthetic ACTH depotpreparation (1 mg, 100 units, tapered over 12 weeks), and Vitamin B-complex or bed rest and Vitamin B-complex intramuscular injections in the same scheme (5)",99.30555555555556
1770,PRECIS-2,"To compare the demographic data and treatment results in both groups, the two-sided Mann-Whitney U test was used with exception of the disease stages (RR, PR, and PP) in which we used the Chi-square test.",fulltext,"To compare the demographic data and treatment results in both groups, the two-sided Mann-Whitney U test was used with exception of the disease stages (RR, PR, and PP) in which we used the Chi-square test.",100.0
1770,PRECIS-2,Assessment of patients was performed by their own neurologist.,fulltext,Assessment of patients was performed by their own neurologist.,100.0
1770,PRECIS-2,"Follow-up was performed in the 6th and 12th week of treatment and 6, 9, and 12 months after the start of treatment.",fulltext,"Follow-up was performed in the 6th and 12th week of treatment and 6, 9, and 12 months after the start of treatment.",100.0
1770,PRECIS-2,"Three neurological departments in the Netherlands (University Hospital Groningen, Streekziekenhuis Almelo, Diaconessenhuis Meppel) participated in this study.",fulltext,"Three neurological departments in the Netherlands (University Hospital Groningen, Streekziekenhuis Almelo, Diaconessenhuis Meppel) participated in this study.",100.0
1771,PRECIS-2,"Following inclusion and baseline testing, participants were randomized (1:1) to a PAE or waitlist group using block randomization, stratified by sex. Allocation was concealed by the sealed envelope principle.",fulltext,"Following inclusion and baseline testing, participants were randomized (1:1) to a PAE or waitlist group using block randomization, stratified by sex. Allocation was concealed by the sealed envelope principle.",100.0
1771,PRECIS-2,"Eighty-six participants were recruited from Danish MS clinics (Aarhus University Hospital, Viborg Regional Hospital, Odense University Hospital, and the MS Clinic of Southern Jutland (Kolding)).",fulltext,"Eighty-six participants were recruited from Danish MS clinics (Aarhus University Hospital, Viborg Regional Hospital, Odense University Hospital, and the MS Clinic of Southern Jutland (Kolding)).",100.0
1771,PRECIS-2,All longitudinal data for the total group and the cognitively impaired subgroup were analyzed using an intention-to-treat linear mixed effects model with time and group as the factors of interest.,fulltext,All longitudinal data for the total group and the cognitively impaired subgroup were analyzed using an intention-to-treat linear mixed effects model with time and group as the factors of interest.,100.0
1771,PRECIS-2,"Eighty-six participants were recruited from Danish MS clinics (Aarhus University Hospital, Viborg Regional Hospital, Odense University Hospital, and the MS Clinic of Southern Jutland (Kolding)). For inclusion and exclusion criteria, see Langeskov-Christensen et al.",fulltext,"Eighty-six participants were recruited from Danish MS clinics (Aarhus University Hospital, Viborg Regional Hospital, Odense University Hospital, and the MS Clinic of Southern Jutland (Kolding)). For inclusion and exclusion criteria, see LangeskovChristensen et al.",99.62264150943396
1771,PRECIS-2,"At baseline (T0), after 24 (T24) and after 48 (T48) weeks, participants performed the BRB-N, the Major Depression Inventory (MDI), and a cardiorespiratory fitness test (VO2-max test). Each test session was separated by at least 48 hours from the last exercise bout.",fulltext,"At baseline (T0), after 24 (T24) and after 48 (T48) weeks, participants performed the BRB-N, the Major Depression Inventory (MDI), and a cardiorespiratory fitness test (VO 2 -max test). Each test session was separated by at least 48 hours from the last exercise bout.",100.0
1771,PRECIS-2,"Supervised PAE sessions were conducted twice weekly during the 24 weeks, with one continuous and one interval exercise session performed each week. In brief, the session volume increased from 30 to 60 minutes during the intervention while the intensity increased from 65% to 95% of individual maximum heart rate (HR max). For further details on exercise modality options and the progressing volume and intensity of the exercise sessions, see Langeskov-Christensen et al.",fulltext,"Supervised PAE sessions were conducted twice weekly during the 24 weeks, with one continuous and one interval exercise session performed each week. In brief, the session volume increased from 30 to 60 minutes during the intervention while the intensity M Langeskov-Christensen, LG Hvid et al. journals.sagepub.com/home/msj 3 increased from 65% to 95% of individual maximum heart rate (HR max ). For further details on exercise modality options and the progressing volume and intensity of the exercise sessions, see LangeskovChristensen et al.",99.7872340425532
1771,PRECIS-2,"The primary outcome was the change in cognitive performance, as measured by the Brief Repeatable Battery of Neuropsychological tests (BRB-N), from baseline to 24 weeks.",fulltext,"n cognitive performance, assessed by a validated cognitive test battery (the Brief Repeatable Battery of Neuropsychological tests (BRB-N)).",60.11904761904761
1771,PRECIS-2,"Exercise adherence was high with 44.8 ± 2.6 completed sessions, corresponding to 93.3 ± 5.4% of the planned sessions.",fulltext,"Exercise adherence was high with 44.8 ± 2.6 completed sessions, corresponding to 93.3 ± 5.4% of the planned sessions.",100.0
1772,PRECIS-2,"Patients randomized to the iDMT group either remained on the same therapy or, following consultation with a physician, were switched immediately to another approved iDMT.",fulltext,"Patients randomized to the iDMT group either remained on the same therapy or, following consultation with a physician, were switched immediately to another approved iDMT.",100.0
1772,PRECIS-2,Study enrollment was completed in October 2011.,fulltext,Study enrollment was completed in October 2011.,100.0
1772,PRECIS-2,"EPOC was a 6-month, randomized, open-label, multicenter, phase 4 study conducted in the USA and Canada.",fulltext,"EPOC was a 6-month, randomized, open-label, multicenter, phase 4 study conducted in the USA and Canada.",100.0
1772,PRECIS-2,"The four iDMTs were subcutaneous (SC) IFN beta-1b (Extavia®, Novartis Pharma AG, Basel, Switzerland, or Betaseron®, Bayer AG, Leverkusen, Germany) 0.25 mg every other day, IM IFN beta-1a (Avonex®, Biogen Idec, Cambridge, MA, USA) 30 μg once weekly, SC IFN beta-1a (Rebif®, Merck Serono, Darmstadt, Germany, and Pfizer Inc., New York City, NY, USA) 22 or 44 μg three times weekly, or SC GA (Copaxone®, Teva Pharmaceutical Industries Ltd, Petah Tikva, Israel) 20 mg once daily.",fulltext,"The four iDMTs were subcutaneous (SC) IFN beta-1b (Extavia®, Novartis Pharma AG, Basel, Switzerland, or Betaseron®, Bayer AG, Leverkusen, Germany) 0.25 mg every other day, IM IFN beta-1a (Avonex®, Biogen Idec, Cambridge, MA, USA) 30 μg once weekly, SC IFN beta-1a (Rebif®, Merck Serono, Darmstadt, Germany, and Pfizer Inc., New York City, NY, USA) 22 or 44 μg three times weekly, or SC GA (Copaxone®, Teva Pharmaceutical Industries Ltd, Petah Tikva, Israel) 20 mg once dail",99.57894736842105
1772,PRECIS-2,"The primary variable was assessed using analysis of covariance, with baseline TSQM Global Satisfaction score as a covariate and treatment group as a main effect.",fulltext,", the primary variable was assessed using analysis of covariance, with baseline TSQM Global Satisfaction score as a covariate and treatment group as a mai",94.40993788819875
1772,PRECIS-2,"Of 1053 patients randomized to treatment, 790 were randomized to fingolimod 0.5 mg and 263 were randomized to an iDMT.",fulltext,". Of 1053 patients randomized to treatment, 790 were randomized to fingolimod 0.5 mg and 263 were randomized to an iDM",98.30508474576271
1772,PRECIS-2,All outcomes were evaluated after 6 months of treatment.,fulltext,All outcomes were evaluated after 6 months of treatment.,100.0
1772,PRECIS-2,"Overall, 1053 patients were randomized 3:1 to switch to fingolimod or remain on iDMT.",fulltext,"Overall, 1053 patients were randomized 3:1 to switch to fingolimod or remain on iDMT.",100.0
1772,PRECIS-2,The primary endpoint was the change in Treatment Satisfaction Questionnaire for Medication (TSQM) Global Satisfaction score.,fulltext,The primary endpoint was the change in Treatment Satisfaction Questionnaire for Medication (TSQM) Global Satisfaction score.,100.0
1772,PRECIS-2,Patients who switched from one iDMT to another or who had been taking a therapy other than one of the four study iDMTs prior to randomization were not included in the analysis.,fulltext,. Patients who switched from one iDMT to another or who had been taking a therapy other than one of the four study iDMTs prior to randomization were not included in the analysi,98.86363636363636
1773,PRECIS-2,"Results are presented as mean ± standard deviation (SD). Shapiro-Wilk normality test was used to assess normal data distribution. To assess any training or detraining effect, as well as any difference between groups, MVIC, torque, average power and muscle endurance raw values were examined using two-way ANOVA with repeated measurements for group and time. Significant interactions and main effects were further analyzed using Bonferroni post-hoc comparisons. The level of significance was set at P < 0.05.",fulltext,"Results are presented as mean ± standard deviation (SD). Shapiro-Wilk normality test was used to assess normal data distribution. To assess any training or detraining effect, as well as any difference between groups, MVIC, torque, average power and muscle endurance raw values were examined using two-way ANOVA with repeated measurements for group and time. Significant interactions and main effects were further analyzed using Bonferroni post-hoc comparisons. The level of significance was set at P < 0.05.",100.0
1773,PRECIS-2,All training sessions took place in MS rehabilitation centers and the patients were continuously supervised by physical therapists.,fulltext,All training sessions took place in MS rehabilitation centers and the patients were continuously supervised by physical therapists.,100.0
1773,PRECIS-2,"The EG improved MVIC (P = 0.004), torque (P = 0.004) and average power (P < 0.001) after the resistance training period (Table 3). Furthermore, the EG presented greater MVIC (P = 0.02), torque (P = 0.025) and average power (P = 0.035) than CG after the training period.",fulltext,"The EG improved MVIC (P = 0.004), torque (P = 0.004) and average power (P < 0.001) after the resistance training period (Table 3). Furthermore, the EG presented greater MVIC (P = 0.02), torque (P = 0.025) and average power (P = 0.035) than CG after the training period.",100.0
1773,PRECIS-2,Forty-two relapsing-remitting MS patients (23 women and 19 men) volunteered to participate in the study. All participants were recruited among six MS rehabilitation centers within the region of Castilla y León (Spain).,fulltext,Forty-two relapsing-remitting MS patients (23 women and 19 men) volunteered to participate in the study. All participants were recruited among six MS rehabilitation centers within the region of Castilla y Le´on (Spain).,99.54128440366972
1773,PRECIS-2,All participants from the EG completed more than 75% of the sessions included in the resistance training program.,fulltext,All participants from the EG completed more than 75% of the sessions included in the resistance training program.,100.0
1773,PRECIS-2,"All testing procedures were selected according to previous studies (De Souza-Teixeira, 2009). Regardless disability status, all the subjects involved in the study were able to perform all the tests.",fulltext,"All testing procedures were selected according to previous studies (De SouzaTeixeira, 2009). Regardless disability status, all the subjects involved in the study were able to perform all the tests.",99.4949494949495
1773,PRECIS-2,Subjects were requested to push with maximal effort during the concentric phase of the movement (90–180◦) and to lower the load (eccentric action; 180–90◦) in a controlled manner.,fulltext,Subjects were requested to push with maximal effort during the concentric phase of the movement (90–180 ◦ ) and to lower the load (eccentric action; 180–90 ◦ ) in a controlled manner.,100.0
1773,PRECIS-2,"After a group meeting where the details of the investigation were described to the patients, including possible risks and discomfort associated to the intervention, a formal invitation to take part in the study was offered.",fulltext,"After a group meeting where the details of the investigation were described to the patients, including possible risks and discomfort associated to the intervention, a formal invitation to take part in the study was offered.",100.0
648,PRECIS-2,"Data were collected at trial entry, immediately after surgery, at hospital discharge (including hospital transfer or death), and at about 6 weeks after delivery. Women who did not return at 6 weeks were located and interviewed by telephone or during a home visit.",fulltext,"Data were collected at trial entry, immediately after surgery, at hospital discharge (including hospital transfer or death), and at about 6 weeks after delivery. Women who did not return at 6 weeks were located and interviewed by telephone or during a home visit.",100.0
648,PRECIS-2,"Information leaflets were made available, in appropriate languages, which explained the trial objectives, the process of trial entry, and follow-up.",fulltext,"Information leaflets were made available, in appropriate languages, which explained the trial objectives, the process of trial entry, and follow-up.",100.0
648,PRECIS-2,"The primary outcome was the composite of death, maternal infectious morbidity, further operative procedures, or blood transfusion (>1 unit of whole blood or packed cells) up to the 6-week follow-up visit.",fulltext,"The primary outcome was a composite of death, maternal infectious morbidity, further operative procedures, or blood transfusion of more than 1 unit of whole blood or packed cells up to the 6-week follow-up visit.",98.0392156862745
648,PRECIS-2,"Pregnant women were eligible if they were to undergo delivery by lower segment caesarean section through a transverse abdominal incision, irrespective of fever in labour, gestational age, or multiple pregnancies.",fulltext,"Pregnant women were eligible if they were to undergo delivery by lower segment caesarean section through a transverse abdominal incision, irrespective of fever in labour, gestational age, or multiple pregnancies.",100.0
648,PRECIS-2,"Each regional coordinator (one per country, except India, which was split into two regions) started and documented a training programme that ensured that surgeons operating within the trial were familiar with the techniques being compared before participating.",fulltext,"Each regional coordinator (one per country, except India, which was split into two regions) started and documented a training programme that ensured that surgeons operating within the trial were familiar with the techniques being compared before participating.",100.0
648,PRECIS-2,"Women were not eligible if there was a clear indication for a particular surgical technique or material to be used that prevented any of the allocated interventions being used, if they had more than one previous caesarean section, or if they had already been recruited into the trial.",fulltext,"Women were not eligible if there was a clear indication for a particular surgical technique or material to be used that prevented any of the allocated interventions being used, if they had more than one previous caesarean section, or if they had already been recruited into the trial.",100.0
648,PRECIS-2,"The procedures for blunt versus sharp abdominal entry were as follows. For sharp entry, the abdomen was entered using a scalpel to divide the abdominal skin. Each subsequent layer of the abdomen was then separately identified and divided using either a scalpel or scissors. In blunt entry, the abdomen was entered using a scalpel to divide the abdominal skin. The scalpel was then used to divide the fat and rectus sheath in the midline and the rectus sheath incision extended manually. The parietal peritoneum was then entered digitally and the defect enlarged manually.",fulltext,"The procedures for blunt versus sharp abdominal entry were as follows. For sharp entry, the abdomen was entered using a scalpel to divide the abdominal skin. Each subsequent layer of the abdomen was then separately identified and divided using either a scalpel or scissors. In blunt entry, the abdomen was entered using a scalpel to divide the abdominal skin. The scalpel was then used to divide the fat and rectus sheath in the midline and the rectus sheath incision extended manually. The parietal peritoneum was then entered digitally and the defect enlarged manually.",100.0
648,PRECIS-2,"All investigators, surgeons, and participants were unmasked to treatment allocation.",fulltext,"All investigators, surgeons, and participants were unmasked to treatment allocation.",100.0
648,PRECIS-2,"The trial was undertaken at 19 sites in Argentina, Chile, Ghana, India, Kenya, Pakistan, and Sudan.",fulltext," was undertaken at 19 sites in Argentina, Chile, Ghana, India, Kenya, Pakistan, and Sudan.",90.9090909090909
648,PRECIS-2,"All non-allocated surgical elements and all other aspects of the caesarean section procedure were undertaken at the discretion of the surgeon. In particular, there were no restrictions on the type of suture material that could be used, and standard measures to achieve haemostasis were employed regardless of the allocated intervention.",fulltext,"All non-allocated surgical elements and all other aspects of the caesarean section procedure were undertaken at the discretion of the surgeon. In particular, there were no restrictions on the type of suture material that could be used, and standard measures to achieve haemostasis were employed regardless of the allocated intervention.",100.0
648,PRECIS-2,"Each participating site, advised by their research ethics committee, decided how to provide trial information to women and seek informed consent.",fulltext,"Each participating site, advised by their research ethics committee, decided how to provide trial information to women and seek informed consent.",100.0
648,PRECIS-2,Women were analysed in the groups into which they were allocated.,fulltext,Women were analysed in the groups into which they were allocated.,100.0
650,PRECIS-2,"Patients could use information from a diary in which they recorded symptoms, thoughts, worries, feelings, and behaviour.",fulltext,"Patients could use information from a diary in which they recorded symptoms, thoughts, worries, feelings, and behaviour.",100.0
650,PRECIS-2,The study involved practice nurses (n=40) providing care to approximately 4000 patients with diabetes.,fulltext,The study involved practice nurses (n=40) providing care to approximately 4000 patients with diabetes.,100.0
650,PRECIS-2,Patients were asked to return the completed questionnaire to the research centre and to give informed consent to be approached if they were found to be eligible for research follow-up measurements.,fulltext,Patients were asked to return the completed questionnaire to the research centre and to give informed consent to be approached if they were found to be eligible for research follow-up measurements.,100.0
650,PRECIS-2,Outcomes were measured at baseline and at 4-month and 12-month follow-ups.,fulltext,Outcomes were measured at baseline and at 4-month and 12-month follow-ups.,100.0
650,PRECIS-2,Practice nurses in the intervention arm (n=19) were trained to integrate SMS into their routine consultations.,fulltext,Practice nurses in the intervention arm (n=19) were trained to integrate SMS into their routine consultations.,100.0
650,PRECIS-2,"SMS included detection of patients with emotional distress and reduced daily functioning, and supporting them when needed through problem solving and reattribution techniques.",fulltext,"SMS included detection of patients with emotional distress and reduced daily functioning, and supporting them when needed through problem solving and reattribution techniques.",100.0
650,PRECIS-2,The primary outcome measure was a dichotomised score on a Visual Analogue Scale that measured the perceived effect of diabetes on daily functioning.,fulltext,The primary outcome measure was a dichotomised score on a Visual Analogue Scale that measured the perceived effect of diabetes on daily functioning.,100.0
650,PRECIS-2,Multilevel analyses showed no significant differences in outcomes between the intervention and control arms.,fulltext,Multilevel analyses showed no significant differences in outcomes between the intervention and control arms.,100.0
650,PRECIS-2,Patients with type 2 diabetes (n=264) selected by a self-administered questionnaire aimed at measuring emotional distress and diabetes-related reduced daily functioning.,fulltext,Patients with type 2 diabetes (n=264) selected by a self-administered questionnaire aimed at measuring emotional distress and diabetes-related reduced daily functioning.,100.0
651,PRECIS-2,Eligible primary care patients 12 to 80 years of age had impaired asthma-related quality of life (Mini Asthma Quality of Life Questionnaire [MiniAQLQ] score ≤6) or inadequate asthma control (Asthma Control Questionnaire [ACQ] score ≥1).,fulltext,Eligible primary care patients 12 to 80 years of age had impaired asthmarelated quality of life (Mini Asthma Quality of Life Questionnaire [MiniAQLQ] score ≤6) or inadequate asthma control (Asthma Control Questionnaire [ACQ] score ≥1).,99.57627118644068
651,PRECIS-2,"The two trials, which were conducted at 53 primary care practices in the United Kingdom, enrolled patients 12 to 80 years of age with a physician’s diagnosis of asthma.",fulltext,"The two trials, which were conducted at 53 primary care practices in the United Kingdom, enrolled patients 12 to 80 years of age with a physician’s diagnosis of asthma.",100.0
651,PRECIS-2,Patients who withdrew from the study continued to receive care from their usual clinician.,fulltext,Patients who withdrew from the study continued to receive care from their usual clinician.,100.0
651,PRECIS-2,"Clinical and lung-function data were recorded by clinic staff who were aware of the treatment assignments. Data collection and statistical analyses were performed by study personnel who were unaware of the treatment assignments; questionnaire-based data were collected under blinded conditions, and routine practice data (including a history of exacerbations) were extracted with the use of dedicated software.",fulltext,"Clinical and lung-function data were recorded by clinic staff who were aware of the treatment assignments. Data collection and statistical analyses were performed by study personnel who were unaware of the treatment assignments; questionnaire-based data were collected under blinded conditions, and routine practice data (including a history of exacerbations) were extracted with the use of dedicated software.",100.0
651,PRECIS-2,The primary outcome measure was the MiniAQLQ score.,fulltext,The primary outcome measure was the MiniAQLQ score.,100.0
651,PRECIS-2,"Practice staffs were asked to provide each patient with a written individualized asthma-action plan. For each of the assigned treatments, choices of individual drugs and devices were made according to normal clinical practice and British asthma guidelines.",fulltext,"Practice staffs were asked to provide each patient with a written individualized asthma-action plan. For each of the assigned treatments, choices of individual drugs and devices were made according to normal clinical practice and British asthma guidelines.",100.0
651,PRECIS-2,The primary effectiveness analysis was an intention-to-treat analysis of the MiniAQLQ score at 2 months (the primary time point) and at 2 years.,fulltext,The primary effectiveness analysis was an intention-to-treat analysis of the MiniAQLQ score at 2 months (the primary time point) and at 2 years.,100.0
651,PRECIS-2,"The protocol discouraged substantial treatment changes between randomization and the 2-month visit. If a patient required a disallowed asthma medication, this fact was noted, and the patient remained in the study.",fulltext,"The protocol discouraged substantial treatment changes between randomization and the 2-month visit. If a patient required a disallowed asthma medication, this fact was noted, and the patient remained in the study.",100.0
651,PRECIS-2,"We randomly assigned patients to 2 years of open-label therapy, under the care of their usual physician, with LTRA (148 patients) or an inhaled glucocorticoid (158 patients) in the first-line controller therapy trial and LTRA (170 patients) or LABA (182 patients) added to an inhaled glucocorticoid in the add-on therapy trial.",fulltext,"We randomly assigned patients to 2 years of open-label therapy, under the care of their usual physician, with LTRA (148 patients) or an inhaled glucocorticoid (158 patients) in the first-line controller therapy trial and LTRA (170 patients) or LABA (182 patients) added to an inhaled glucocorticoid in the add-on therapy trial.",100.0
655,PRECIS-2,"The main efficacy analysis used analysis of covariance (ANCOVA) techniques to test for differences between groups in outcome variables at the 12-month visit, adjusted for baseline values.",fulltext,"The main efficacy analysis used analysis of covariance (ANCOVA) techniques to test for differences between groups in outcome variables at the 12-month visit, adjusted for baseline values.",100.0
655,PRECIS-2,"Patients in the IG were asked to continue at home with a similar training schedule to that completed in the hospital. They were provided with, for the 12-month follow-up period, a telerehabilitation kit (mobile phone, pulse oximeter, dumbbells and exercise bicycle) along with a user guide with detailed instructions on the use of the mobile device to deliver data collected to the web-based platform after completion of each scheduled session.",fulltext,"Patients in the IG were asked to continue at home with a similar training schedule to that completed in the hospital. They were provided with, for the 12-month follow-up period, a telerehabilitation kit (mobile phone, pulse oximeter, dumbbells and exercise bicycle) along with a user guide with detailed instructions on the use of the mobile device to deliver data collected to the web-based platform after completion of each scheduled session ",100.0
655,PRECIS-2,"Following completion of this programme, patients were randomly allocated (baseline visit, 0) to either the TelePR programme [intervention group (IG)] or the standard, usual care programme [control group (CG)].",fulltext,"Following completion of this programme, patients were randomly allocated (baseline visit, 0) to either the TelePR programme [intervention group (IG)] or the standard, usual care programme [control group (CG)].",100.0
655,PRECIS-2,This was a multicentre open-label pragmatic parallel-group randomized clinical trial involving 13 hospitals and was conducted between 2014 and 2017.,fulltext,This was a multicentre open-label pragmatic parallel-group randomized clinical trial involving 13 hospitals and was conducted between 2014 and 2017,99.32432432432432
655,PRECIS-2,"After the randomization visit, follow-up appointments were arranged for both groups at 3, 9 and 12 months. At each follow-up visit, the general health status of the patient was assessed, medical treatment was revised and optimized, educational reinforcement was provided, 6-minute walk test (6MWT) and spirometry tests were carried out and HRQoL measures were taken.",fulltext,"After the randomization visit, follow-up appointments were arranged for both groups at 3, 9 and 12 months. At each follow-up visit, the general health status of the patient was assessed, medical treatment was revised and optimized, educational reinforcement was provided, 6-minute walk test (6MWT) and spirometry tests were carried out and HRQoL measures were taken.",100.0
655,PRECIS-2,"A patient in the IG arm was classified as a non-complier if he/she did not perform scheduled exercises for at least 8 consecutive weeks, unless there were clear clinical reasons not to.",fulltext," patient in the IG arm was classified as a non-complier if he/she did not perform scheduled exercises for at least 8 consecutive weeks, unless there were clear clinical reasons not to.",99.45945945945947
655,PRECIS-2,Exercise tolerance (the ability to sustain exercise) was assessed using distance covered in the 6MWT.,fulltext,Exercise tolerance (the ability to sustain exercise) was assessed using distance covered in the 6MWT.,100.0
655,PRECIS-2,"Patient selection criteria were having a diagnosis of moderate-to-severe COPD (a Body mass index, Airflow obstruction, dyspnoea and Exercise capacity [BODE] index score of 3–7) according to international guidelines",fulltext,"Patient selection criteria were having a diagnosis of moderate-to-severe COPD (a Body mass index, Airflow obstruction, dyspnoea and Exercise capacity [BODE] index score of 3–7) according to international guidelines",100.0
655,PRECIS-2,"Recruited patients (recruitment visit, −1) attended an initial 8-week outpatient-based PR programme conducted in each hospital rehabilitation department.",fulltext,"Recruited patients (recruitment visit, −1) attended an initial 8-week outpatient-based PR programme conducted in each hospital rehabilitation department.",100.0
657,PRECIS-2,The GroupCoreDIST intervention was conducted by 6 physical therapists in 6 municipalities in Norway.,fulltext,The GroupCoreDIST intervention was conducted by 6 physical therapists in 6 municipalities in Norway.,100.0
657,PRECIS-2,"Enrollment started in September 2015, and follow-up was completed in September 2016.",fulltext,"Enrollment started in September 2015, and follow-up was completed in September 2016.",100.0
657,PRECIS-2,"The physical therapists individualized the exercises by tailoring them according to each individual’s symptoms, disability level, and general well-being, and they intensified the exercises by increasing number of repetitions, level of difficulty, and/or by adding motor-cognitive dual tasks as movement quality improved.",fulltext,"The physical therapists individualized the exercises by tailoring them according to each individual’s symptoms, disability level, and general well-being, and they intensified the exercises by increasing number of repetitions, level of difficulty, and/or by adding motor-cognitive dual tasks as movement quality improved.",100.0
657,PRECIS-2,"Assessments were undertaken at baseline and at weeks 7, 18, and 30.",fulltext,"Assessments were undertaken at baseline and at weeks 7, 18, and 30.",100.0
657,PRECIS-2,"Outcomes were measured with the Trunk Impairment Scale–Norwegian Version, Mini Balance Evaluation Systems Test, and Patient Global Impression of Change–Balance.",fulltext,"Outcomes were measured with the Trunk Impairment Scale–Norwegian Version, Mini Balance Evaluation Systems Test, and Patient Global Impression of Change–Balance.",100.0
657,PRECIS-2,"One individual missed all postintervention tests, leaving 79 participants in the intention-to-treat analysis.",fulltext,"One individual missed all postintervention tests, leaving 79 participants in the intention-to-treat analysis.",100.0
657,PRECIS-2,"The physical therapists received a booklet with descriptions and photos of all exercises and variations, as well as the theoretical framework for the intervention.",fulltext,"The physical therapists received a booklet with descriptions and photos of all exercises and variations, as well as the theoretical framework for the intervention.",100.0
657,PRECIS-2,Eighty people with Expanded Disability Status scores of 1 to 6.5 participated in this trial.,fulltext,Eighty people with Expanded Disability Status scores of 1 to 6.5 participated in this trial.,100.0
657,PRECIS-2,Participants in the intervention group were encouraged not to seek any physical therapy other than GroupCoreDIST during the 6 weeks of the intervention.,fulltext,Participants in the intervention group were encouraged not to seek any physical therapy other than GroupCoreDIST during the 6 weeks of the intervention.,100.0
662,PRECIS-2,"Inclusion criteria were diagnosis of PPMS or SPMS, Internet access and some level of distress determined by a score of 3 or greater on the General Health Questionnaire (GHQ-12).",fulltext,"Inclusion criteria were diagnosis of PPMS or SPMS, Internet access and some level of distress determined by a score of 3 or greater on the General Health Questionnaire (GHQ-12).",100.0
662,PRECIS-2,"The eight chapters, one for each session, introduced key mindfulness concepts, addressed issues common to progressive MS, and described homework for the week ahead.",fulltext,"The eight chapters, one for each session, introduced key mindfulness concepts, addressed issues common to progressive MS, and described homework for the week ahead.",100.0
662,PRECIS-2,Participants were sent a headset and webcam together with instructions of how to set up Skype.,fulltext,Participants were sent a headset and webcam together with instructions of how to set up Skype.,100.0
662,PRECIS-2,The treatment phase took place between February 2013 and July 2013. We delivered the programme in eight hour-long sessions over an eight-week period via Skype video conferences.,fulltext,The treatment phase took place between February 2013 and July 2013. We delivered the programme in eight hour-long sessions over an eight-week period via Skype video conferences.,100.0
662,PRECIS-2,We conducted all group comparisons on an intention-to-treat basis where we analysed participants in the group to which they were randomised.,fulltext,We conducted all group comparisons on an intention-to-treat basis where we analysed participants in the group to which they were randomised.,100.0
662,PRECIS-2,"Participants completed online questionnaires at baseline (prior to randomisation), post-intervention and three-month follow-up.",fulltext,"Participants completed online questionnaires at baseline (prior to randomisation), post-intervention and three-month follow-up.",100.0
662,PRECIS-2,We recruited potential participants through adverts on the MS Society website and from National Health Service (NHS) MS centres across the UK.,fulltext,We recruited potential participants through adverts on the MS Society website and from National Health Service (NHS) MS centres across the UK.,100.0
662,PRECIS-2,"Participants were encouraged to keep a diary of home practice, but, in fact, very few did record it.",fulltext,"Participants were encouraged to keep a diary of home practice, but, in fact, very few did record it.",100.0
662,PRECIS-2,The GHQ is designed to measure general levels of distress.,fulltext,The GHQ 17 is designed to measure general levels of distress.,100.0
663,PRECIS-2,"Analyses were carried out as intention-to-treat, where all participants who completed the baseline assessment were included regardless of their adherence to the allocated intervention.",fulltext,"Analyses were carried out as intention-to-treat, where all participants who completed the baseline assessment were included regardless of their adherence to the allocated intervention.",100.0
663,PRECIS-2,"Exclusion criteria were as follows: co-morbidity in terms of cognitive disorders or alcohol abuse (based on clinical judgment), pathologies that did not allow systematic PRT >1 session/week within the last 3 months.",fulltext,"Exclusion criteria were as follows: co-morbidity in terms of cognitive disorders or alcohol abuse (based on clinical judgment), pathologies that did not allow systematic PRT >1 session/week within the last 3 months.",100.0
663,PRECIS-2,"Physiotherapists with experience in providing BMCT managed the programs. The therapists were instructed to aim for a level of difficulty, where the participants experienced failure but still reached successful execution in more than 50% of the attempts/time.",fulltext,"Physiotherapists with experience in providing BMCT managed the programs. The therapists were instructed to aim for a level of difficulty, where the participants experienced failure but still reached successful execution in more than 50% of the attempts/time.",100.0
663,PRECIS-2,"The primary outcomes were the T25FW and the SSST. Fatigue impact, self-perceived gait function, 6-minute walk, balance, and muscle strength were secondary outcomes.",fulltext," Primary outcomes were the T25FW and the SSST. Fatigue impact, self-perceived gait function, 6-minute walk, balance, and muscle strength were secondary outcomes.",98.17073170731707
663,PRECIS-2,"The inclusion criteria were as follows: age > 18, confirmed diagnosis of MS, Expanded Disability Status Scale (EDSS): 2.0–6.5, Six Spot Step Test (SSST) score > 8 seconds or Timed 25-Foot Walk (T25FW) > 5 seconds, relapse-free within the past 8 weeks, and no adjustment of disease-modifying medication or medication that affects gait performance and spasticity within the past 8 weeks.",fulltext,"The inclusion criteria were as follows: age > 18, confirmed diagnosis of MS, Expanded Disability Status Scale (EDSS): 2.0–6.5, Six Spot Step Test (SSST) score > 8 seconds or Timed 25-Foot Walk (T25FW) > 5 seconds, relapse-free within the past 8 weeks, and no adjustment of disease-modifying medication or medication that affects gait performance and spasticity within the past 8 weeks.",100.0
663,PRECIS-2,All training sessions were supervised by physiotherapists who were trained to deliver the intervention.,fulltext,All training sessions were supervised by physiotherapists who were trained to deliver the intervention.,100.0
663,PRECIS-2,"Participants were included from September 2016 to October 2018, after being invited via seven MS clinics (specified in “Acknowledgements” section) and targeted advertisements sent out via the Danish MS Society.",fulltext,"Participants were included from September 2016 to October 2018, after being invited via seven MS clinics (specified in “Acknowledgements” section) and targeted advertisements sent out via the Danish MS Society.",100.0
663,PRECIS-2,The interventions lasted 10 weeks. A total of 71 participants with impaired mobility (Timed 25-Foot Walk (T25FW) > 5 seconds or Six Spot Step Test (SSST) > 8 seconds) were enrolled.,fulltext,The interventions lasted 10 weeks. A total of 71 participants with impaired mobility (Timed 25-Foot Walk (T25FW) > 5 seconds or Six Spot Step Test (SSST) > 8 seconds) were enrolled.,100.0
663,PRECIS-2,"The exercises were conducted in machines that targeted the specified muscle groups, but type of machines could vary between centers.",fulltext,"The exercises were conducted in machines that targeted the specified muscle groups, but type of machines could vary between centers.",100.0
663,PRECIS-2,The follow-up test was performed within 7 days of the last intervention session or after the last day of being on the waitlist.,fulltext,The follow-up test was performed within 7 days of the last intervention session or after the last day of being on the waitlist.,100.0
664,PRECIS-2,"The inclusion criteria for the trial were clinical diagnosis of MS, as defined by the modified McDonald criteria, with an Expanded Disability Status Scale (EDSS) score of 1.0–6.5, and able to walk a 10-metre distance; aged 18–65 years; clinically stable for at least four weeks prior to entering the study; physically able to participate in exercise three times per week; able to provide written informed consent.",fulltext,"The inclusion criteria for the trial were clinical diagnosis of MS, as defined by the modified McDonald criteria, 9 with an Expanded Disability Status Scale (EDSS) score of 1.0–6.5, and able to walk a 10-metre distance; aged 18–65 years; clinically stable for at least four weeks prior to entering the study; physically able to participate in exercise three times per week; able to provide written informed consent.",100.0
664,PRECIS-2,"The supervised exercise sessions incorporated cognitive-behavioural techniques (e.g. goal setting, finding social support, understanding the costs/benefits of exercise, etc.) to promote long-term participation in physical activity.",fulltext,"The supervised exercise sessions incorporated cognitivebehavioural techniques (e.g. goal setting, finding social support, understanding the costs/benefits of exercise, etc.) to promote long-term participation in physical activity.",99.56709956709958
664,PRECIS-2,Outcomes were blindly assessed at baseline and at three and nine months after randomisation.,fulltext,Outcomes were blindly assessed at baseline and at three and nine months after randomisation.,100.0
664,PRECIS-2,"The programme was designed to be pragmatic and accessible, taking into account exercise preferences and giving choices.",fulltext,"The programme was designed to be pragmatic and accessible, taking into account exercise preferences and giving choices.",100.0
664,PRECIS-2,"All analyses were by intention to treat, whereby participants were analysed in the arm to which they were randomised irrespective of whether they complied with the intervention.",fulltext,"All analyses were by intention to treat, whereby participants were analysed in the arm to which they were randomised irrespective of whether they complied with the intervention.",100.0
664,PRECIS-2,A total of 120 PwMS were recruited via the Sheffield MS Clinic and flyers/community adverts displayed at the local South Yorkshire MS Society branches.,fulltext,A total of 120 PwMS were recruited via the Sheffield MS Clinic and flyers/community adverts displayed at the local South Yorkshire MS Society branches.,100.0
664,PRECIS-2,The primary outcome was self-reported exercise behaviour (Godin Leisure Time Exercise Questionnaire (GLTEQ)).,fulltext,The primary outcome was self-reported exercise behaviour (Godin Leisure Time Exercise Questionnaire (GLTEQ)).,100.0
664,PRECIS-2,"During weeks 1–6, participants attended two supervised sessions per week at a university exercise research facility and engaged in one additional self-directed exercise session in their home environment.",fulltext,"During weeks 1–6, participants attended two supervised sessions per week at a university exercise research facility and engaged in one additional self-directed exercise session in their home environment.",100.0
664,PRECIS-2,"Participants were encouraged to seek out opportunities to exercise in the local community (e.g. healthy living centres, health walks, fitness centres, swimming pools, etc.), based on their individual preferences.",fulltext,"Participants were encouraged to seek out opportunities to exercise in the local community (e.g. healthy living centres, health walks, fitness centres, swimming pools, etc.), based on their individual preferences.",100.0
665,PRECIS-2,"Inclusion criteria were: age of 18 years or above; BDI score of at least 14 on two consecutive occasions and no treatment from psychologist, psychotherapist or psychiatrist within the last three months.",fulltext,"Inclusion criteria were: age of 18 years or above; BDI score of at least 14 on two consecutive occasions and no treatment from psychologist, psychotherapist or psychiatrist within the last three months.",100.0
665,PRECIS-2,The study was coordinated by a research team based at the University of Sheffield.,fulltext,"s Research Unit, ScHARR, University of Sheffield,",50.0
665,PRECIS-2,The intervention was delivered via a computerized cognitive behavioral therapy (CCBT) program.,fulltext, computerised cognitive behavioural therapy (CCBT) ,52.127659574468076
665,PRECIS-2,"Participants were identified from clinic attenders, MS nurse patient visits and from patients with MS from the caseload of the neuropsychologist.",fulltext,"participants were identified from clinic attenders, MS nurse patient visits and from patients with MS from the caseload of the neuropsychologist.",100.0
665,PRECIS-2,Participants were asked to complete at least four CCBT sessions.,fulltext,) completed at least four CCBT sessions.,60.9375
665,PRECIS-2,The study was conducted at two UK centres.,fulltext,onnaires at two UK centres ,52.38095238095239
665,PRECIS-2,The primary outcome was the mean change in self-reported symptoms of depression as measured on the BDI.,fulltext,The primary clinical endpoint was the mean change in self-reported symptoms of depression as measured on the BDI.,95.14563106796116
665,PRECIS-2,The primary analysis was an intention-to-treat analysis.,fulltext,thods Primary analysis was an Intention To Treat (ITT) analysis ,98.21428571428571
665,PRECIS-2,Participants were followed up at 8 and 21 weeks post-randomization.,fulltext,participants in each arm were lost to follow-up at 21 weeks post-randomisation.,86.56716417910448
666,PRECIS-2,"Adherence to treatment when the dosing schedule differs is complicated, because missing one dose has potentially differential impacts on treatment. Thus, adherence was measured using the self-reported MS-TAQ.",fulltext,"Adherence to treatment when the dosing schedule differs is complicated, because missing one dose has potentially differential impacts on treatment. Thus, adherence was measured using the self-reported MS-TAQ.",100.0
666,PRECIS-2,Patients who stopped treatment with the study drug before Month 6 were considered early treatment discontinuation patients and attended an early treatment discontinuation visit.,fulltext,Patients who stopped treatment with the study drug before Month 6 were considered early treatment discontinuation patients and attended an early treatment discontinuation visit.,100.0
666,PRECIS-2,"Patients in the study received treatment for 6 months, and the study was conducted during a period starting in August 2015 and ending in January 2017.",fulltext,"Patients in the study received treatment for 6 months, and the study was conducted during a period starting in August 2015 and ending in January 2017.",100.0
666,PRECIS-2,Patients (N = 861) were randomly assigned 1:1 to receive GA20 (n = 430) or GA40 (n = 431) during the core phase.,fulltext,Patients (N = 861) were randomly assigned 1:1 to receive GA20 (n = 430) or GA40 (n = 431) during the core phase.,100.0
666,PRECIS-2,"Patients also participated in self-reported, daily at-home MSQ assessments on Days 1 through 7 after the baseline visit.",fulltext,"Patients also participated in self-reported, daily athome MSQ assessments on Days 1 through 7 after the baseline visit.",99.16666666666667
666,PRECIS-2,"Patient-reported endpoints were analyzed based on the full analysis set (FAS), which included all patients in the ITT population who received at least 1 dose of study drug and had at least 1 post-baseline assessment.",fulltext,"Patient-reported endpoints were analyzed based on the full analysis set (FAS), which included all patients in the ITT population who received at least 1 dose of study drug and had at least 1 post-baseline assessment.",100.0
666,PRECIS-2,"The CONFIDENCE study was a multinational, multicenter, randomized, parallel-group, phase 4, open-label study conducted at 88 study centers in 14 countries (Russia, Poland, Italy, France, Croatia, US [including Puerto Rico], Mexico, Spain, Austria, Turkey, Belgium, Argentina, Germany, and Finland) across different geographic regions.",fulltext,"The CONFIDENCE study was a multinational, multicenter, randomized, parallel-group, phase 4, open-label study conducted at 88 study centers in 14 countries (Russia, Poland, Italy, France, Croatia, US [including Puerto Rico], Mexico, Spain, Austria, Turkey, Belgium, Argentina, Germany, and Finland) across different geographic regions.",100.0
666,PRECIS-2,The primary endpoint was patient-reported medication satisfaction using the Medication Satisfaction Questionnaire (MSQ).,fulltext,The primary endpoint was patient-reported medication satisfaction using the Medication Satisfaction Questionnaire (MSQ).,100.0
668,PRECIS-2,"Each exercise session was completed in around 45 min, and at the end of each session there was a 30-min recovery period when the participants had refreshments and time to socialize.",fulltext,"Each exercise session was completed in around 45 min, and at the end of each session there was a 30-min recovery period when the participants had refreshments and time to socialize.",100.0
668,PRECIS-2,"Volunteers were excluded if they had an acute exacerbation of MS within 2 months of starting the program, had benign or progressive/relapsing types of MS, had a serious unstable medical condition, had any concurrent condition, for example stroke, or had participated in a PRT program in the 6 months before training started.",fulltext,"Volunteers were excluded if they had an acute exacerbation of MS within 2 months of starting the program, had benign or progressive/relapsing types of MS, had a serious unstable medical condition, had any concurrent condition, for example stroke, or had participated in a PRT program in the 6 months before training started.",100.0
668,PRECIS-2,"The experimental group completed a 10-week (two times per week), PRT program in one of four community gymnasiums in metropolitan and regional areas.",fulltext,"The experimental group completed a 10-week (two times per week), PRT program in one of four community gymnasiums in metropolitan and regional areas.",100.0
668,PRECIS-2,People with relapsing–remitting MS were randomly allocated to either a PRT program,fulltext,People with relapsing–remitting MS were randomly allocated to either a PRT program,100.0
668,PRECIS-2," Outcomes were recorded at baseline, week 10 and week 22.",fulltext," Outcomes were recorded at baseline, week 10 and week 22.",100.0
668,PRECIS-2,Two-minute rest periods were given between each exercise set.,fulltext,Two-minute rest periods were given between each exercise set.,100.0
668,PRECIS-2, or usual care plus an attention and social program,fulltext, or usual care plus an attention and social program,100.0
668,PRECIS-2,Categorical outcome variables were analyzed with relative risk ratios.,fulltext,Categorical outcome variables were analyzed with relative risk ratios.,100.0
668,PRECIS-2,"After completing their 10-week intervention programs, participants were asked to return to their usual activities and not to continue or commence resistance training until after the follow-up assessment session.",fulltext,"After completing their 10-week intervention programs, participants were asked to return to their usual activities and not to continue or commence resistance training until after the follow-up assessment session.",100.0
668,PRECIS-2,"To determine whether the PRT group improved more than the control group immediately after the 10-week program, data were analyzed with analysis of covariance using the baseline measures as covariates, a method that has been recommended for the analysis of continuous data measured at baseline and follow-up in randomized controlled trials.",fulltext,"To determine whether the PRT group improved more than the control group immediately after the 10week program, data were analyzed with analysis of covariance using the baseline measures as covariates, a method that has been recommended for the analysis of continuous data measured at baseline and follow-up in randomized controlled trials.",99.70501474926253
668,PRECIS-2,"Participants were recruited through a statewide organization providing education and support to people with MS, and a large specialist MS outpatient clinic.",fulltext,"Participants were recruited through a statewide organization providing education and support to people with Dodd et al. 1363 MS, and a large specialist MS outpatient clinic.",100.0
668,PRECIS-2,"Outcome measurements were taken three times: at baseline, after 10 weeks to determine the immediate effects of the intervention, and after a further 12 weeks (week 22) to determine if any benefits from the program had been sustained.",fulltext,"Outcome measurements were taken three times: at baseline, after 10 weeks to determine the immediate effects of the intervention, and after a further 12 weeks (week 22) to determine if any benefits from the program had been sustained.",100.0
668,PRECIS-2,Recruitment information flyers were sent by mail to all potential participants registered on the mailing lists of both organizations.,fulltext,Recruitment information flyers were sent by mail to all potential participants registered on the mailing lists of both organizations.,100.0
668,PRECIS-2,"Participants in the control group received ‘usual care’ plus a social program. ‘Usual care’ could include habitual exercise participants engaged in, or therapy, provided it did not include PRT.",fulltext,"Participants in the control group received ‘usual care’ plus a social program. ‘Usual care’ could include habitual exercise participants engaged in, or therapy, provided it did not include PRT.",100.0
668,PRECIS-2,"Each program was attended by a group of up to 12 participants, and they were supervised by up to three experienced trainers (physiotherapists and registered personal sports trainers).",fulltext,"Each program was attended by a group of up to 12 participants, and they were supervised by up to three experienced trainers (physiotherapists and registered personal sports trainers).",100.0
668,PRECIS-2,In developing the control program careful consideration was given to optimizing participant attendance.,fulltext,In developing the control program careful consideration was given to optimizing participant attendance.,100.0
668,PRECIS-2,Changes in walking endurance were measured with the 2-minute walk test (2MWT).,fulltext,Changes in walking endurance were measured with the 2-minute walk test (2MWT).,100.0
668,PRECIS-2,"The training intensity was based on recommendations of the American College of Sports Medicine (2009) and consisted of two sets of 10–12 repetitions of each exercise, at a training intensity of 10–12 repetition maximum (that is, only 12 consecutive repetitions of each exercise could be completed before muscle fatigue was reached).",fulltext,"The training intensity was based on recommendations of the American College of Sports Medicine (2009) 7 and consisted of two sets of 10–12 repetitions of each exercise, at a training intensity of 10–12 repetition maximum (that is, only 12 consecutive repetitions of each exercise could be completed before muscle fatigue was reached).",100.0
668,PRECIS-2,"To be included, people had to be aged 18 years or more, have a confirmed diagnosis of relapsing–remitting MS, have an Ambulation Index score of 2, 3 or 4 (mild to moderate walking disabilities), and have received medical clearance to participate.",fulltext,"To be included, people had to be aged 18 years or more, have a confirmed diagnosis of relapsing–remitting MS, have an Ambulation Index score 19 of 2, 3 or 4 (mild to moderate walking disabilities), and have received medical clearance to participate.",100.0
668,PRECIS-2,Changes in maximal walking speed were measured by recording the time taken to walk the middle 10 m of a level 14-m walkway using a stop-watch.,fulltext,Changes in maximal walking speed were measured by recording the time taken to walk the middle 10 m of a level 14-m walkway using a stopwatch.,99.29577464788733
669,PRECIS-2,"The primary outcome measures were physical fitness, walking capacity and perceived ability, functional mobility, and quality of life.",fulltext,"The primary outcome measures were physical fitness, walking capacity and perceived ability, functional mobility, and quality of life.",100.0
669,PRECIS-2,pwMS received training instructions by email. They were asked to train three times weekly according to a personalized training intensity schedule that was based on their baseline aerobic capacity.,fulltext,pwMS received training instructions by email. They were asked to train three times weekly according to a personalized training intensity schedule that was based on their baseline aerobic capacity.,100.0
669,PRECIS-2,"During the first weeks, training consisted of longer walking bouts, interspersed with short 1′ running bouts. The relative amount of running gradually increased until participants were able to run 5 km without interruption at 12 weeks.",fulltext,"During the first weeks, training consisted of longer walking bouts, interspersed with short 1′ running bouts. The relative amount of running gradually increased until participants were able to run 5 km without interruption at 12 weeks.",100.0
669,PRECIS-2,Intention-to-treat analysis was performed.,fulltext,Intention-to-treat analysis was performed.,100.0
669,PRECIS-2,"Evaluation was performed at REVAL by a study nurse, a PhD student in Rehabilitation Sciences and Physiotherapy, and the project dedicated researcher (MSc in exercise physiology, PhD).",fulltext,"Evaluation was performed at REVAL by a study nurse, a PhD student in Rehabilitation Sciences and Physiotherapy, and the project dedicated researcher (MSc in exercise physiology, PhD).",100.0
669,PRECIS-2,"Adults with MS were recruited through announcements at REVAL rehabilitation research institute (UHasselt), Flemish MS rehabilitation centers and MS Society, and Move-to-Sport.",fulltext,"Adults with MS were recruited through announcements at REVAL rehabilitation research institute (UHasselt), Flemish MS rehabilitation centers and MS Society, and Move-to-Sport.",100.0
669,PRECIS-2,Adults diagnosed with MS were included based on the ability to walk 5 km without rest or use of assistive device.,fulltext,Adults diagnosed with MS were included based on the ability to walk 5 km without rest or use of assistive device.,100.0
669,PRECIS-2,Participants were asked to weekly upload data to allow remote supervision of the training adherence by the research assistant.,fulltext,Participants were asked to weekly upload data to allow remote supervision of the training adherence by the research assistant.,100.0
669,PRECIS-2,Participants who completed the training program showed high adherence.,fulltext,Participants who completed the training program showed high adherence.,100.0
670,PRECIS-2,"The data were analyzed on an intention-to-treat basis, with a focus on the differences between mean MSSE values of the control and intervention groups.",fulltext,"The data were analyzed on an intention-to-treat basis, with a focus on the differences between mean MSSE values of the control and intervention groups.",100.0
670,PRECIS-2,"All treatment plans were approved by the clinical teacher in charge. The teacher also monitored treatment delivery, which involved the application of a variety of techniques appropriate to the client’s needs.",fulltext,"All treatment plans were approved by the clinical teacher in charge. The teacher also monitored treatment delivery, which involved the application of a variety of techniques appropriate to the client’s needs.",100.0
670,PRECIS-2,The outcome measures for the current research were the scores yielded by the Multiple Sclerosis Self-Efficacy (MSSE) survey.,fulltext,The outcome measures for the current research were the scores yielded by the Multiple Sclerosis Self-Efficacy (MSSE) survey.,100.0
670,PRECIS-2,"The inclusion criterion for the study was a diagnosis of multiple sclerosis, and therefore the spectrum of clinical presentations was broad, as would be expected in this client population. All treatment plans were approved by the clinical teacher in charge. The teacher also monitored treatment delivery, which involved the application of a variety of techniques appropriate to the client’s needs.",fulltext,"The inclusion criterion for the study was a diagnosis of multiple sclerosis, and therefore the spectrum of clinical presentations was broad, as would be expected in this client population. All treatment plans were approved by the clinical teacher in charge. The teacher also monitored treatment delivery, which involved the application of a variety of techniques appropriate to the client’s needs.",100.0
670,PRECIS-2,"Clients were provided with information about the clinic by the local chapter of the Multiple Sclerosis Society, and self-selected on that basis.",fulltext,"Clients were provided with information about the clinic by the local chapter of the Multiple Sclerosis Society, and self-selected on that basis.",100.0
670,PRECIS-2,"For both treatment and control groups, self-efficacy scores were obtained before the first treatment, mid-treatment series, after the last treatment in the series, four weeks after the final treatment, and again eight weeks after the final treatment had been received.",fulltext,"For both treatment and control groups, self-efficacy scores were obtained before the first treatment, midtreatment series, after the last treatment in the series, four weeks after the final treatment and again eight weeks after the final treatment had been received.",99.25373134328358
670,PRECIS-2,"Participants were clients seen in the multiple sclerosis clinics at Sutherland-Chan School, in which the study was conducted. Clients were provided with information about the clinic by the local chapter of the Multiple Sclerosis Society, and self-selected on that basis. Of the fifteen study participants, all had previously received a diagnosis of multiple sclerosis.",fulltext,"Participants were clients seen in the multiple sclerosis clinics at Sutherland-Chan School, in which the study was conducted. Clients were provided with information about the clinic by the local chapter of the Multiple Sclerosis Society, and self-selected on that basis. Of the fifteen study participants, all had previously received a diagnosis of multiple sclerosis.",100.0
670,PRECIS-2,"The research project was explained, and written informed consent was obtained. The Multiple Sclerosis Self-Efficacy (MSSE) survey was then given to the client to complete.",fulltext,"The research project was explained, and written informed consent was obtained. The Multiple Sclerosis Self-Efficacy (MSSE) survey was then given to the client to complete.",100.0
671,PRECIS-2,"The primary analysis of the primary outcome, AMCA score at 36 weeks, followed a modified intention-to-treat approach, regardless of compliance to the intervention, but did exclude patients who were deemed ineligible after randomisation, those who withdrew from the trial and were unwilling for their previously collected data to be used, or those who did not provide baseline and week 36 measurements (ie, there was no imputation of missing baseline or week 36 scores for the primary analysis), and used an analysis of covariance (ANCOVA) approach.",fulltext,"The primary analysis of the primary outcome, AMCA score at 36 weeks, followed a modified intention to treat approach, regardless of compliance to the inter vention, but did exclude patients who were deemed ineligible after randomisation, those who withdrew from the trial and were unwilling for their previously collected data to be used, or those who did not provide baseline and week 36 measurements (ie, there was no imputation of missing baseline or week 36 scores for the primary analysis), and used an analysis of covariance (ANCOVA) approach.",100.0
671,PRECIS-2,"The AMCA score (range 0–76) is the sum of two subscores. The functional activity subscore (16 items, each scored 0–3) comprises key functional activities of the trunk and lower limbs, such as rolling in bed, sit-to-stand, and sitting and standing balance. The lower limb movement subscore (14 items, each scored 0–2) rates motor impairment by grading hip and knee flexion and knee flexion and dorsiflexion in lying, sitting, and standing positions.",fulltext,"The AMCA score (range 0–76) is the sum of two subscores. The functional activity subscore (16 items, each scored 0–3) comprises key functional activities of the trunk and lower limbs, such as rolling in bed, sit to stand, and sitting and standing balance. The lower limb movement subscore (14 items, each scored 0–2) rates motor impairment by grading hip and knee flexion and knee flexion and dorsiflexion in lying, sitting, and standing positions.",100.0
671,PRECIS-2,"Participants were asked to stand in the frame for 30 min three times per week over 20 weeks, and to record the frequency and duration of each stand in a daily diary.",fulltext,"Participants were asked to stand in the frame for 30 min three times per week over 20 weeks, and to record the frequency and duration of each stand in a daily diary.",100.0
671,PRECIS-2,"The SUMS study was an individually randomised, controlled, pragmatic, multi centre, superiority trial with masked outcome assessments in people with progressive mul tiple sclerosis.",fulltext,"The SUMS study was an individually randomised, controlled, pragmatic, multi centre, superiority trial with masked outcome assessments in people with progressive mul tiple sclerosis.",100.0
671,PRECIS-2,"Participants were recruited through eight health care organisations, including the UK National Health Service (NHS) Trusts, social enterprises, and third sector multiple sclerosis therapy centres, in two regions (Devon–Cornwall and East Anglia) of the UK.",fulltext,"Participants were recruited through eight health care organisations, including the UK National Health Service (NHS) Trusts, social enterprises, and third sector multiple sclerosis therapy centres, in two regions (Devon–Cornwall and East Anglia) of the UK.",100.0
671,PRECIS-2,Individuals were invited consecutively until the allocated number of standing frames (dependent on commissioning costs) at each health care organisation had been reached.,fulltext,Individuals were invited consecutively until the allocated number of standing frames (dependent on commissioning costs) at each health care organisation had been reached.,100.0
671,PRECIS-2,"At the end of the 20-week period, participants were encouraged to continue to regularly stand, although no further physiotherapy support was provided.",fulltext,"At the end of the 20 week period, participants were encouraged to continue to regularly stand, although no further physiotherapy support was provided.",100.0
671,PRECIS-2,All participants received their usual health and social service input throughout the study period.,fulltext,All participants received their usual health and social service input throughout the study period.,100.0
671,PRECIS-2,The primary outcome was motor function as measured by the Amended Motor Club Assessment (AMCA) score at the primary endpoint of 36 weeks post randomisation.,fulltext,The prim ary outcome was motor function as measured by the Amended Motor Club Assessment (AMCA) score 23 at the primary endpoint of 36 weeks post randomisation.,100.0
673,PRECIS-2,"The FI-led classes were not pre-defined, as the aim was to establish whether these classes were effective when encountered by those with MS in the community.",fulltext,"The FI-led classes were not pre-defined, as the aim was to establish whether these classes were effective when encountered by those with MS in the community.",100.0
673,PRECIS-2,"The primary outcome measure was the physical component of the Multiple Sclerosis Impact Scale-29, version 2 (MSIS-29v2), a patient-reported outcome measure that assesses the physical impact of MS.",fulltext,"The primary outcome measure was the physical component of the Multiple Sclerosis Impact Scale29, version 2 (MSIS-29v2), a patient-reported outcome measure that assesses the physical impact of MS.",99.48979591836735
673,PRECIS-2,"Participants allocated to PT-led exercise attended a mean of 8.1 classes (95% CI 7.5, 8.5). Participants allocated to yoga attended a mean of 7.8 classes (95% CI 7.2, 8.3) and participants allocated to FI-led exercise attended a mean of 7.3 classes (95% CI 6.7, 7.9).",fulltext,"Participants who were allocated to PT-led exercise attended a mean of 8.1 classes (95% CI 7.5, 8.5). Participants allocated to yoga attended a mean of 7.8 classes (95% CI 7.2, 8.3) and participants allocated to FI-led exercise attended a mean of 7.3 classes (95% CI 6.7, 7.9).",100.0
673,PRECIS-2,"Participants were referred to the project by themselves, their care-giver, MSI, chartered physiotherapists, neurologists, general practitioners or clinical nurse specialists.",fulltext,"participants were referred to the project by themselves, their care-giver, MSI, chartered physiotherapists, neurologists, general practitioners or clinical nurse specialists.",100.0
673,PRECIS-2,Eligible participants were over 18 years of age and had a diagnosis of MS that was confirmed by a consultant physician or neurologist.,fulltext,Eligible participants were over 18 years of age and had a diagnosis of MS that was confirmed by a consultant physician or neurologist.,100.0
673,PRECIS-2,"Outcome was assessed at week 24 for the intervention groups only, as it was felt that withholding a potentially beneficial treatment for longer than 12 weeks, from the controls, could be considered unethical.",fulltext,"Outcome was assessed at week 24 for the intervention groups only, as it was felt that withholding a potentially beneficial treatment for longer than 12 weeks, from the controls, could be considered unethical.",100.0
673,PRECIS-2,Treatment fidelity was optimized by the instructors and participants documenting programme adherence.,fulltext,Treatment fidelity was optimised by the instructors and participants documenting programme adherence.,99.00990099009901
673,PRECIS-2,"All statistical analyses were conducted using Predictive Analytics Software (PASW) Statistics 17. The distribution of the data was analyzed using histograms, Quantile-Quantile plots, and the Kolmogorov-Smirnov statistic.",fulltext,"All statistical analyses were conducted using Predictive Analytics Software (PASW) Statistics 17. The distribution of the data was analysed using histograms, QuantileQuantile plots and the Kolmogorov-Smirnov statistic.",98.63636363636363
673,PRECIS-2,"Persons with MS were excluded if they had a previous relapse or began steroid therapy in the 12 weeks prior to participating in the first assessment, were pregnant, or had a comorbidity that severely impacted their ability to safely participate in exercise.",fulltext,"Persons with MS were excluded if they had a previous relapse or began steroid therapy in the 12 weeks prior to participating in the first assessment, were pregnant, or had a comorbidity that severely impacted their ability to safely participate in exercise.",100.0
673,PRECIS-2,"All interventions took place in groups of eight, for an hour per week, for 10 weeks. They were delivered in community centres such as local gyms, hotels, and health centres.",fulltext,"All interventions took place in groups of eight, for an hour per week, for 10 weeks. They were delivered in community centres such as local gyms, hotels and health centres.",99.42196531791907
673,PRECIS-2,The PT-led exercise provided was pre-defined. It consisted of a circuit-style class of exercises that were either resisted by body weight or by the addition of free weights.,fulltext,The PT-led exercise provided was pre-defined. It consisted of a circuit-style class of exercises that were either resisted by body weight or by the addition of free weights.,100.0
673,PRECIS-2,"Participants were enrolled following their eligibility assessments, performed by the regional offices of MSI.",fulltext,"Participants were enrolled following their eligibility assessments, performed by the regional offices of MSI.",100.0
674,PRECIS-2,The trial is registered with ClinicalTrials.gov (NCT00548405). All procedures were approved by local institutional ethics review boards of participating sites.,fulltext, This trial is registered with ClinicalTrials.gov (NCT00548405). All procedures were approved by local institutional ethics review boards of participating sites,98.74213836477988
674,PRECIS-2,"Percentage of patients with recent prestudy relapse was also equivalent between groups (alemtuzumab, 32%; SC IFN-b-1a, 33%).",fulltext,"Percentage of patients with recent prestudy relapse was also equivalent between groups (alemtuzumab, 32%; SC IFN-b-1a, 33%).",100.0
674,PRECIS-2,The trial's primary outcome was the time to first relapse.,fulltext,bility outcome measures in therapeutic trials of relap,53.448275862068975
674,PRECIS-2,Differences in study drug administration and unique adverse event profiles precluded effective double-blinding.,fulltext, Differences in study drug administration and unique adverse event profiles precluded effective double-blinding,99.09909909909909
674,PRECIS-2,"Blinded raters performed EDSS assessments at baseline, every 3 months, and when relapse was suspected.",fulltext,"Blinded raters performed EDSS assessments at baseline, every 3 months, and when relapse was suspected.",100.0
674,PRECIS-2,"From baseline to month 24, alemtuzumab patients were more likely than SC IFN-b-1a patients to show EDSS improvement (p < 0.0001; figure 1A).",fulltext," From baseline to month 24, alemtuzumab patients were more likely than SC IFN-b-1a patients to show EDSS improvement (p , 0.0001; figure 1A)",99.28571428571429
674,PRECIS-2,"CARE-MS II was a 2-year, randomized, rater-blinded, active comparator-controlled, head-to-head, trial of alemtuzumab (Lemtrada; Sanofi Genzyme, Cambridge, MA; 12 mg/day on 5 consecutive days at month 0 and on 3 consecutive days at month 12) vs SC IFN-b-1a (Rebif; EMD Serono, Rockland, MA; 44 mg 3 times weekly) in patients with RRMS with inadequate response to prior DMTs ($1 relapse during IFN-b or glatiramer acetate [GA] treatment [received for $6 months]).",fulltext,"CARE-MS II was a 2-year, randomized, rater-blinded, active comparator-controlled, head-to-head, trial of alemtuzumab (Lemtrada; Sanofi Genzyme, Cambridge, MA; 12 mg/day on 5 consecutive days at month 0 and on 3 consecutive days at month 12) vs SC IFN-b-1a (Rebif; EMD Serono, Rockland, MA; 44 mg 3 times weekly) in patients with RRMS with inadequate response to prior DMTs ($1 relapse during IFN-b or glatiramer acetate [GA] treatment [received for $6 months]).",100.0
674,PRECIS-2,The primary analysis was based on the intention-to-treat population.,prompt, Primary analysis: To what extent are all data included in the analysi,55.88235294117647
675,PRECIS-2,"MBI closely followed the program of mindfulness-based stress reduction and included 1) a personal intake interview to define realistic goals of participants and establish personal rapport; 2) 8 weekly 2.5-hour classes in mindfulness practices (10 –15 participants/group; exercises did not exceed patients’ level of functioning); 3) one Saturday, 7-hour session at week 6; 4) homework assignments (approximately 40 minutes/day), emphasized as essential to success of the program; 5) a postintervention interview to evaluate personal experiences, goal attainment, and future maintenance of acquired skills.",fulltext,"MBI closely followed the program of mindfulness-based stress reduction 23 and included 1) a personal intake interview to define realistic goals of participants and establish personal rapport; 2) 8 weekly 2.5-hour classes in mindfulness practices (10 –15 participants/group; exercises did not exceed patients’ level of functioning); 3) one Saturday, 7-hour session at week 6; 4) homework assignments (approximately 40 minutes/day), emphasized as essential to success of the program; 5) a postintervention interview to evaluate personal experiences, goal attainment, and future maintenance of acquired skills.",100.0
675,PRECIS-2,"Employing intention-to-treat analysis, MBI, compared with UC, improved nonphysical dimensions of primary outcomes at postintervention and follow-up (p < 0.002); effect sizes, 0.4–0.9 posttreatment and 0.3–0.5 at follow-up.",fulltext,"Employing intention-to-treat analysis, MBI, compared with UC, improved nonphysical dimensions of primary outcomes at postintervention and follow-up (p  0.002); effect sizes, 0.4–0.9 posttreatment and 0.3–0.5 at follow-up.",100.0
675,PRECIS-2,"Primary outcomes included disease-specific and disease-aspecific HRQOL, depression, and fatigue.",fulltext,"Primary outcomes included disease-specific and disease-aspecific HRQOL, depression, and fatigue.",100.0
675,PRECIS-2,"All patients in the usual care (UC) group (and in the MBI group) received regular, currently optimal medical care during the duration of the study, as provided by the neurology department of the hospital.",fulltext,"All patients in the usual care (UC) group (and in the MBI group) received regular, currently optimal medical care during the duration of the study, as provided by the neurology department of the hospital.",100.0
675,PRECIS-2,"Assessments were made at baseline, postintervention, and 6 months follow-up.",fulltext,"Assessments were made at baseline, postintervention, and 6 months follow-up.",100.0
675,PRECIS-2,A total of 150 patients were randomly assigned to the intervention (n = 76) or to UC (n = 74).,fulltext,A total of 150 patients were randomly assigned to the intervention (n = 76) or to UC (n = 74).,100.0
675,PRECIS-2,"Eligible patients completed all preintervention assessments before randomization. Randomization was conducted by the principal investigator who had no prior contact with patients and was fully blinded to all patient information, except study identification number of patients.",fulltext,"Eligible patients completed all preintervention assessments before randomization. Randomization was conducted by the principal investigator who had no prior contact with patients and was fully blinded to all patient information, except study identification number of patients.",100.0
675,PRECIS-2,"Mindfulness exercises included observation of sensory, affective, and cognitive domains of perceptible experience.",fulltext,"Mindfulness exercises included observation of sensory, affective, and cognitive domains of perceptible experience.",100.0
675,PRECIS-2,"MBI participants reported practicing, on average, 5.11 times/week (SD 2.24; CI 4.59 –5.64 times), a total time average of 76% of assigned homework (SD 13.80; CI 72.76%–79.25%).",fulltext,"MBI participants reported practicing, on average, 5.11 times/week (SD 2.24; CI 4.59 –5.64 times), a total time average of 76% of assigned homework (SD 13.80; CI 72.76%–79.25%).",100.0
677,PRECIS-2,the patient and the therapist had a weekly scheduled videoconference.,fulltext,the patient and the therapist had a weekly scheduled videoconference.,100.0
677,PRECIS-2,all measurements were performed at the centre where the patient had been treated.,fulltext,all measurements were performed at the centre where the patient had been treated.,100.0
677,PRECIS-2,"the intervention group underwent one month of usual care, followed by approximately 4 training sessions with the H-caD system in the hospital. the actual intervention with the H-caD system at home consisted of one month, whereby the patients had an average of one training session a day lasting 30 minutes for at least 5 days a week.",fulltext,"the intervention group underwent one month of usual care, followed by approximately 4 training sessions with the H-caD system in the hospital. the actual intervention with the H-caD system at home consisted of one month, whereby the patients had an average of one training session a day lasting 30 minutes for at least 5 days a week.",100.0
677,PRECIS-2,the physicians of the three rehabilitation centres included patients following the inclusion and exclusion criteria.,fulltext,the physicians of the three rehabilitation centres included patients following the inclusion and exclusion criteria.,100.0
677,PRECIS-2,"Subjects were eligible for recruiting if they met the following criteria: (1) age > 18 years; (2) established diagnosis of the specific pathological condition MS, stroke or tBI; (3) nine hole peg test (NHPG) performed in more than 25 seconds; (4) ability to move at least one peg in 180 seconds during the NHPG; (5) sufficient autonomous functioning; (6) internet connection or telephone line and reachable internet provider; (7) clinical status stable; (8) discharged from hospital or rehabilitation setting – person lives at home.",fulltext,"subjects were eligible for recruiting if they met the following criteria: (1) age > 18 years; (2) established diagnosis of the specific pathological condition MS, stroke or tBI; (3) nine hole peg test (NHPG) performed in more than 25 seconds; (4) ability to move at least one peg in 180 seconds during the NHPG; (5) sufficient autonomous functioning; (6) internet connection or telephone line and reachable internet provider; (7) clinical status stable; (8) discharged from hospital or rehabilitation setting – person lives at home.",100.0
677,PRECIS-2,the goal of the clinical trial was to show that the effect of a new treatment (H-caD) is equal effective as the existing treatment (usual care).,fulltext,the goal of the clinical trial was to show that the effect of a new treatment (H-caD) is equal effective as the existing treatment (usual care).,100.0
677,PRECIS-2,"the main research question in this validation trial was: is the use of the H-caD system for one month at least as good as usual care for the arm/hand function in stroke, tBI and MS patients?",fulltext,"lItAtIon clInIcAl trIAl was: is the use of the H-caD system for one month at least as good as usual care for the arm/hand function in stroke, tBI and MS patients?",82.63157894736842
677,PRECIS-2,"Patients were recruited from Unità Organica di riabilitazione Intensiva Neuromotoria (UOrIN, Italy), Foundation Institute Guttmann (FPING, Spain) and from National Multiple Sclerosis centre (NMSc, Belgium).",fulltext,"Patients were recruited from Unità Organica di riabilitazione Intensiva Neuromotoria (UOrIN, Italy), Foundation Institute Guttmann (FPING, Spain) and from National Multiple Sclerosis centre (NMSc, Belgium).",100.0
677,PRECIS-2,the patients in the intervention group maintained the same function on grasping objects and on gross movements during the complete testing period (ara test).,fulltext,the patients in the intervention group maintained the same function on grasping objects and on gross movements during the complete testing period (ara test).,100.0
678,PRECIS-2,Patients in South East London who were severely affected by MS were referred by clinicians to the trial.,fulltext,Patients in South East London who were severely affected by MS were referred by clinicians to the trial.,100.0
678,PRECIS-2,"There was no significant difference over time in POS-8, but at Week 12, caregiver burden ZBI scores had reduced in the fast-track group and increased slightly in the control group.",fulltext,"There was no significant difference over time in POS-8, but at Week 12, caregiver burden ZBI scores had reduced in the fast-track group and increased slightly in the control group.",100.0
678,PRECIS-2,The trial was conducted in South East London.,fulltext,"the trial (Fig. 1). Inclusion criteria were patients in South East London,",86.66666666666667
678,PRECIS-2,"We planned an intention-to-treat analysis, irrespective of whether patients were assessed as having palliative care needs or the nature of contact with the PCT.",fulltext,"We planned an intention-to-treat analysis, irrespective of whether patients were assessed as having palliative care needs or the nature of contact with the PCT.",100.0
678,PRECIS-2,"The PCT comprised one part-time consultant in palliative medicine, one part-time clinical nurse specialist, one administrator, and one psychosocial worker, and was based in a large teaching hospital.",fulltext," PCT. 18,20 This comprised one part-time consultant in palliative medicine, one part-time clinical nurse specialist, one administrator, and one psychosocial worker, and was based in a large teaching hospital.",98.49246231155779
678,PRECIS-2,"After baseline interview, patients were randomly allocated to either a multiprofessional palliative care team (PCT) immediately (fast track) or the control care group who continued best usual care for three months and then were offered the PCT.",fulltext,"After baseline interview, patients were randomly allocated to either a multiprofessional palliative care team (PCT) immediately (fast track) or the control care group who continued best usual care for three months and then were offered the PCT.",100.0
678,PRECIS-2,"Patients were visited in their own homes or sometimes outpatient clinics, nursing homes, or hospital.",fulltext,"Patients were visited in their own homes or sometimes outpatient clinics, nursing homes, or hospital.",100.0
678,PRECIS-2,"Data were collected at baseline, 6, 12, 18, and 26 weeks on use of services, patient symptoms, other outcomes, and caregiver burden.",fulltext,"Data were collected at baseline, 6, 12, 18, and 26 weeks on use of services, patient symptoms, other outcomes, and caregiver burden.",100.0
678,PRECIS-2,The trial's primary outcome was to evaluate the cost-effectiveness of a new palliative care service for people with multiple sclerosis (MS).,fulltext, We evaluated the cost-effectiveness of a new palliative care service for people with multiple sclerosis (MS).,77.14285714285715
679,PRECIS-2,"CDT was given during three consecutive days in Zorghotel Spelderholt, Beekbergen, the Netherlands, a facility especially equipped for the accommodation of people with impaired health.",fulltext,"CDT was given during three consecutive days in Zorghotel Spelderholt, Beekbergen, the Netherlands, a facility especially equipped for the accommodation of people with impaired health.",100.0
679,PRECIS-2,"Eligibility criteria for patients: diagnosis RRMS since at least one year, EDSS score ≤4.0, no symptoms suggestive of a relapse, no relapse in the preceding four weeks, willing and capable of participating in the investigations, and having access to the internet for performing the web-based assessments.",fulltext,"Eligibility criteria for patients: diagnosis RRMS since at least one year, EDSS score ≤4.0, no symptoms suggestive of a relapse, no relapse in the preceding four weeks, willing and capable of participating in the investigations, and having access to the internet for performing the web-based assessments.",100.0
679,PRECIS-2,"Patients were recruited from all over the Netherlands by the patient organisation NMSF, Rotterdam, the Netherlands.",fulltext,"pants were recruited from all over the Netherlands by the patient organisation NMSF, Rotterdam, the Netherlands.",97.3913043478261
679,PRECIS-2,"The multidisciplinary team included a psychiatrist, psychiatric nurse, neurologist, registered nurse specialized in MS, physiotherapist, dance therapist, and a person with MS.",fulltext,"The multidisciplinary team included a psychiatrist, psychiatric nurse, neurologist, registered nurse specialized in MS, physiotherapist, dance therapist, and a person with MS.",100.0
679,PRECIS-2,"All endpoints were analyzed according to the intention-to-treat principle using an ANCOVA with the 6-month value as dependent variable, and condition, baseline value, disease duration and gender as independent variables.",fulltext,"All endpoints were analyzed according to the intention-to-treat principle using an ANCOVA with the 6-month value as dependent variable, and condition, baseline value, disease duration and gender as independent variables.",100.0
679,PRECIS-2,"During CDT, safety aspects and adverse events were assessed and documented by the multidisciplinary team at the end of each day.",fulltext,"During CDT, safety aspects and adverse events were assessed and documented by the multidisciplinary team at the end of each day.",100.0
679,PRECIS-2,"Assessments were at baseline and at one, three and six months follow-up via online questionnaires.",fulltext,"Assessments were at baseline and at one, three and six months follow-up via online questionnaires ",100.0
679,PRECIS-2,"The components of CDT are large group sessions, small group sessions, consultations (carrousel), a theatre evening, and start of the day with a joint activity (optional).",fulltext," Components. CDT’s components are large group sessions, small group sessions, consultations (carrousel), a theatre evening, and start of the day with a joint activity (optional) ",97.05882352941177
679,PRECIS-2,"The primary study outcome was the change in control self-efficacy, assessed by the Multiple Sclerosis Self-Efficacy Scale (MSSES), at six months.",fulltext,"The primary study outcome was the change in control self-efficacy, assessed by the Multiple Sclerosis Self-Efficacy Scale (MSSES), at six months.",100.0
680,PRECIS-2,"All statistical analyses included a sample of 30 participants at pre, post and 20 weeks follow up and were undertaken controlling for gender and ambulation status.",fulltext," measure. All statistical analyses included a sample of 30 participants at pre, post and 20 weeks follow up and were undertaken controlling for gender and ambulati",93.86503067484662
680,PRECIS-2,Inclusion criteria were: 1) having a definite diagnosis of MS from a neurologist; 2) being within 5 years of receiving a diagnosis of MS; 3) scoring at least 10 on the Beck Depression Inventory-II (BDI-II) [26]; 4) not currently undertaking other psychological treatment for depressive or anxiety symptoms for the length of participation in the current trial; 5) speak English fluently; 6) no current or lifetime diagnosis of psychosis; 7) no current substance dependency; 8) no gross cognitive impairment; and 9) no changes to medications prior and during involvement in the trial.,fulltext,Inclusion criteria were: 1) having a definite diagnosis of MS from a neurologist; 2) being within 5 years of receiving a diagnosis of MS; 3) scoring at least 10 on the Beck Depression Inventory-II (BDI-II) [26]; 4) not currently undertaking other psychological treatment for depressive or anxiety symptoms for the length of participation in the current trial; 5) speak English fluently; 6) no current or lifetime diagnosis of psychosis; 7) no current substance dependency; 8) no gross cognitive impairment; and 9) no changes to medications prior and during involvement in the trial.,100.0
680,PRECIS-2,"Participants were recruited through neurologists working in a large MS outpatient clinic at the hospital, advertisements on MS related websites and local press releases.",fulltext,"Participants were recruited through neurologists working in a large MS outpatient clinic at the hospital, advertisements on MS related websites and local press releases.",100.0
680,PRECIS-2,A senior clinical psychologist and a provisional clinical psychologist (supervised by the clinical psychologist) provided the intervention.,fulltext,A senior clinical psychologist and a provisional clinical psychologist (supervised by the clinical psychologist) provided the intervention.,100.0
680,PRECIS-2,"The study took place at a large teaching and research hospital in Melbourne, Australia.",fulltext,"The study took place at a large teaching and research hospital in Melbourne, Australia.",100.0
680,PRECIS-2,The primary outcome was level of depressive symptoms using the Beck Depression Inventory-II (BDI-II).,fulltext,The primary outcome was level of depressive symptoms using the Beck Depression Inventory-II (BDI-II).,100.0
680,PRECIS-2,"Follow up assessments ended April, 2015.",fulltext,"Follow up assessments ended April, 2015.",100.0
680,PRECIS-2,There were no drop-outs and participants completed all treatment modules.,fulltext,There were no drop-outs and participants completed all treatment modules.,100.0
680,PRECIS-2,All sessions (apart from the first session which was 1.5 h) were 1 h in duration and took place in a clinic room at the hospital.,fulltext,All sessions (apart from the first session which was 1.5 h) were 1 h in duration and took place in a clinic room at the hospital.,100.0
681,PRECIS-2,"Participants had a confirmed diagnosis of multiple sclerosis, an Extended Disability Status Scale score of 5 (ambulatory without aid or rest for about 200 m) to 6.5 (constant bilateral assistance required to walk about 20 m without resting), stable rehabilitation and drug therapy for 30 days before entry into the study, cognitive scores of over 24 on the Mini-Mental State Examination, and access to the intervention sites using their own or public transport.",fulltext,"Participants had a confirmed diagnosis of multiple sclerosis, an Extended Disability Status Scale 33 score of 5 (ambulatory without aid or rest for 580 Clinical Rehabilitation 26(7) about 200 m) to 6.5 (constant bilateral assistance required to walk about 20 m without resting), stable rehabilitation and drug therapy for 30 days before entry into the study, cognitive scores of over 24 on the Mini-Mental State Examination 34 and access to the intervention sites using their own or public transport.",100.0
681,PRECIS-2,"Outcome measures were carried out within the local hospital's rehabilitation unit. They were taken at baseline, after 8 and 12 weeks of the intervention period (i.e., either the exercise class or usual care).",fulltext,"Outcome measures were carried out within the local hospital’s rehabilitation unit. They were taken at baseline, after 8 and 12 weeks of the intervention period (i.e. either the exercise class or usual care).",99.51923076923077
681,PRECIS-2,The primary outcome measure was 25-foot (7.6 m) walk time.,fulltext,The primary outcome measure was 25-foot (7.6 m) walk time.,100.0
681,PRECIS-2,The intervention took place at two different geographical locations (Site A and Site B).,fulltext,The intervention took place at two different geographical locations (Site A and Site B).,100.0
681,PRECIS-2,"The group session involved a 10-minute warm-up of aerobic and stretching components, 30–40 minutes of circuit exercises (Appendix 1 on-line), designed to train aerobic endurance, resistance and balance, and a 5–10 minute cool-down, involving aerobic work, stretching and relaxation.",fulltext,"The group session involved a 10-minute warm-up of aerobic and stretching components, 30–40 minutes of circuit exercises (Appendix 1 on-line), designed to train aerobic endurance, resistance and balance, and a 5–10 minute cool-down, involving aerobic work, stretching and relaxation.",100.0
681,PRECIS-2,"Participants completed a circuit of 8–12 different exercises for 1 minute each, having a rest (of a minimum of 1 minute) before moving to the next exercise. Not all exercises were performed at all classes, and in week 9 a fifth level of difficulty was added to some of the exercises to encourage progress.",fulltext,"Participants completed a circuit of 8–12 different exercises for 1 minute each, having a rest (of a minimum of 1 minute) before moving to the next exercise. Not all exercises were performed at all classes, and in week 9 a fifth level of difficulty was added to some of the exercises to encourage progress.",100.0
681,PRECIS-2,Of the 873 patients on the clinical register for multiple sclerosis 159 patients were deemed suitable for the study. These people were sent invitation letters and participant information sheets.,fulltext,Of the 873 patients on the clinical register for multiple sclerosis 159 patients were deemed suitable for the study. These people were sent invitation letters and participant information sheets.,100.0
681,PRECIS-2,Participants were provided with exercise progress cards and were asked to record which level they performed each exercise at each session.,fulltext,Participants were provided with exercise progress cards and were asked to record which level they performed each exercise at each session.,100.0
681,PRECIS-2,"All outcome measures were analysed on the basis of intention to treat, with all variables summarized and comparisons made between groups and over time.",fulltext,"All outcome measures were analysed on the basis of intention to treat, with all variables summarized and comparisons made between groups and over time.",100.0
682,PRECIS-2,"Specific inclusion criteria were (1) ambulatory (can walk 100 m, be capable of walking 100 metres without a walking aid corresponding to a classification of ⩽5.5 on the Expanded Disability Status Scale (EDSS), even if they do use an aid for daily activities; and (2) self-reported to be sedentary or irregularly active at time of study entry (i.e. do not exercise 30 minutes or more twice per week of moderate to vigorous activity). This latter criterion was subsequently confirmed using activity monitoring for 7 days post-enrolment.",fulltext,"Specific inclusion criteria were (1) ambulatory (can walk 100 m, be capable of walking 100 metres without a walking aid corresponding to a classification of ⩽5.5 on the Expanded Disability Status Scale (EDSS), 10 even if they do use an aid for daily activities; and (2) self-reported to be sedentary or irregularly active at time of study entry (i.e. do not exercise 30 minutes or more twice per week of moderate to vigorous activity). This latter criterion was subsequently confirmed using activity monitoring for 7 days post-enrolment.",100.0
682,PRECIS-2,"Two different types of exercise interventions were contrasted. MSTEP©, a personally adapted exercise regimen including a variety of exercises targeting endurance, muscular, and core strength, balance, flexibility, muscular power, and speed of movement. The goal of the MSTEP© programme is to promote regular bouts of activity most days per week, encouraging a balance between rest and activity, and taking into consideration the physical and emotional status and capacity of the person. A unique feature of MSTEP© was to specifically target cardio-aerobic capacity through cardio-intensive exercise prescribed two times per week (Push Days) using the concept of interval training.",fulltext,"Two different types of exercise interventions were contrasted. MSTEP©, a personally adapted exercise regimen including a variety of exercises targeting endurance, muscular, and core strength, balance, flexibility, muscular power, and speed of movement. The goal of the MSTEP© programme is to promote regular bouts of activity most days per week, encouraging a balance between rest and activity, and taking into consideration the physical and emotional status and capacity of the person. A unique feature of MSTEP© was to specifically target cardio-aerobic capacity through cardio-intensive exercise prescribed two times per week (Push Days) using the concept of interval training.",100.0
682,PRECIS-2,"The primary analysis was of the proportion of people making an absolute improvement at the final time point, 12 months. The planned sample size was 240, 120 per group, based on 80% power, significance level of 0.05, and a hypothesized 20% response in the Guideline group and a 50% response in the MSTEP© group.",fulltext,"The primary analysis was of the proportion of people making an absolute improvement at the final time point, 12 months. The planned sample size was 240, 120 per group, based on 80% power, significance level of 0.05, and a hypothesized 20% response in the Guideline group and a 50% response in the MSTEP© group.",100.0
682,PRECIS-2,"Once the assessments were completed, people were randomized. Randomization was stratified by site and people were assigned either to MSTEP© or General Guidelines using blocked randomization with random block sizes of 2, 4, and 6. The randomization was done using the web-based programme (http://www.randomization.com) by a statistician. Once the outcome assessments were completed, the statistician revealed the group assignment to the intervention staff.",fulltext,"Once the assessments were completed, people were randomized. Randomization was stratified by site and people were assigned either to MSTEP© or General Guidelines using blocked randomization with random block sizes of 2, 4, and 6. The randomization was done using the web-based programme (http://www.randomization.com) by a statistician. Once the outcome assessments were completed, the statistician revealed the group assignment to the intervention staff.",100.0
682,PRECIS-2,"As there were four visits during the first year with four opportunities for missing data, the first set of analyses addressed whether the pattern of missing data was associated with the outcomes measured in this study. As the outcomes were continuous, linear regression was used with study status (missing baseline, baseline only, drop-out before end, or completer) as the explanatory variable, with baseline only serving as the reference category.",fulltext,"As there were four visits during the first year with four opportunities for missing data, the first set of analyses addressed whether the pattern of missing data was associated with the outcomes measured in this study. As the outcomes were continuous, linear regression was used with study status (missing baseline, baseline only, drop-out before end, or completer) as the explanatory variable, with baseline only serving as the reference category.",100.0
682,PRECIS-2,"All had their exercise regimens reviewed during the intervention year at the evaluations which were scheduled at 3, 6, and 12 months. Evaluators were blinded to the group that the participant was in.",fulltext,"All had their exercise regimens reviewed during the intervention year at the evaluations which were scheduled at 3, 6, and 12 months. Evaluators were blinded to the group that the participant was in.",100.0
682,PRECIS-2,"People were recruited from four multiple sclerosis clinics in three Canadian cities and from posting on media sites. During the clinic visit, the treating neurologist introduced the study to their patients and referred them to the research assistant who further explained the study and assessed eligibility. Those contacting the research team directly were assessed for eligibility over the phone and sent information on the study electronically.",fulltext,"People were recruited from four multiple sclerosis clinics in three Canadian cities and from posting on media sites. During the clinic visit, the treating neurologist introduced the study to their patients and referred them to the research assistant who further explained the study and assessed eligibility. Those contacting the research team directly were assessed for eligibility over the phone and sent information on the study electronically.",100.0
682,PRECIS-2,The primary outcome was exercise capacity as measured by peak oxygen consumption (VO 2peak) using a modified Bruce protocol on the cycle ergometer. The effectiveness indicator is the proportion of people making a 10% change in VO 2peak at the end of the 12-month intervention.,fulltext,The primary outcome was exercise capacity as measured by peak oxygen consumption (VO 2peak ) using a modified Bruce protocol on the cycle ergometer. The effectiveness indicator is the proportion of people making a 10% change 12 in VO 2peak at the end of the 12-month intervention.,100.0
682,PRECIS-2,"The trial protocol for this two-group, assessor-blind, stratified, randomized 1:1, pragmatic, trial was published in 2013. The trial is registered with ClinicalTrials.gov NCT01611987. The trial received ethical approval from the Montreal Neurological Hospital Research Ethics Board (NEU-12-005) and the Health Research Ethics Board, University of Manitoba (H2014:226).",fulltext,"The trial protocol for this two-group, assessorblind, stratified, randomized 1:1, pragmatic, trial was published in 2013. 9 The trial is registered with ClinicalTrials.gov NCT01611987. The trial received ethical approval from the Montreal Neurological Hospital Research Ethics Board (NEU-12-005) and the Health Research Ethics Board, University of Manitoba (H2014:226) ",99.72826086956522
684,PRECIS-2,"People moderately to severely affected by MS were recruited from the MS Service, NHS Ayrshire and Arran.",fulltext,"People moderately to severely affected by MS were recruited from the MS Service, NHS Ayrshire and Arran.",100.0
684,PRECIS-2,Subjects were assessed at the beginning and at the end of the eight-week intervention period (i.e. either physiotherapy or control) and then again eight weeks later.,fulltext,Subjects in both groups were assessed at the beginning and at the end of the eight-week intervention period (i.e. either physiotherapy or control) and then again eight weeks later.,100.0
684,PRECIS-2,Setting: Community; subjects’ homes.,fulltext,Setting: Community; subjects’ homes.,100.0
684,PRECIS-2,"Subjects had a definite diagnosis of primary or secondary progressive MS, and an EDSS of between 6.5 (constant bilateral assistance required to walk about 20 metres without resting) to 8 (essentially restricted to bed or chair or perambulated in wheelchair, but may be out of bed much of the day, retains many self-care functions and generally has effective use of arms).",fulltext,"Subjects had a definite diagnosis of primary or secondary progressive MS, and an EDSS of between 6.5 (constant bilateral assistance required to walk about 20 metres without resting) to 8 (essentially restricted to bed or chair or perambulated in wheelchair, but may be out of bed much of the day, retains many selfcare functions and generally has effective use of ",98.11320754716981
684,PRECIS-2,"Subjects assigned to Group 1 received physiotherapy, twice weekly for eight weeks, by an experienced domiciliary physiotherapist within their home.",fulltext,"Subjects assigned to Group 1 received physiotherapy, twice weekly for eight weeks, by an experienced domiciliary physiotherapist within their home.",100.0
684,PRECIS-2,The average number of sessions received by participants was 14.8 (out of a possible 16).,fulltext,The average number of sessions received by participants was 14.8 (out of a possible 16).,100.0
684,PRECIS-2,"The MS impact scale (MSIS 29), which is a measure of the physical and psychological impact of MS, was the primary outcome measure for the study.",fulltext,"The MS impact scale (MSIS 29), which is a measure of the physical and psychological impact of MS, 12 was the primary outcome measure for the study.",100.0
684,PRECIS-2,All outcome variables were summarized and comparisons made between groups and over time.,fulltext,All outcome variables were summarized and comparisons made between groups and over time.,100.0
684,PRECIS-2,"Each subject therefore received core treatments aimed to maximize strength, flexibility and function.",fulltext,"Each subject therefore received core treatments aimed to maximize strength, flexibility and function.",100.0
685,PRECIS-2,"Main outcome measures included the Barthel Index, a measure of mobility, the SF-36, and the Standard Day Dependency Record (SDDR) which measures the need for assistance with daily activities.",fulltext,"Main outcome measures: These included the Barthel Index, a measure of mobility, the SF-36, and the Standard Day Dependency Record (SDDR) which measures the need for assistance with daily activities.",100.0
685,PRECIS-2,"Participants were volunteers with MS who were recruited through voluntary organizations, were community based and lived in West London and in counties contiguous with Greater London.",fulltext,"Participants were volunteers with MS who were recruited through voluntary organizations, were community based and lived in West London and in counties contiguous with Greater London.",100.0
685,PRECIS-2,"Individuals were assigned to group or one-to-one sessions by the health professional in consultation with each person, and based on their needs and wishes.",fulltext,"Individuals were assigned to group or one to one sessions by the health professional in consultation with each person, and based on their needs and wishes.",100.0
685,PRECIS-2,Follow-up assessments were conducted six months after baseline.,fulltext, assessments were conducted six months after baseline.,85.71428571428572
685,PRECIS-2,Participants were invited to join the study and were accepted when informed consent had been given in writing.,fulltext,Participants were invited to join the study and were accepted when informed consent had been given in writing.,100.0
685,PRECIS-2,The study was conducted with people with MS living in the community.,fulltext,The study was conducted with people with MS living in the community.,100.0
685,PRECIS-2,Scale scores on the outcome measures in the control and intervention group were compared in two ways. The clinical impact of the intervention was assessed using change scores and an effect size statistic.,fulltext,Scale scores on the outcome measures in the control and intervention group were compared in two ways. The clinical impact of the intervention was assessed using change scores and an effect size statistic.,100.0
685,PRECIS-2,The only selection criterion was that the diagnosis of MS was confirmed by the general practitioner. There were no exclusion criteria.,fulltext,The only selection criterion was that the diagnosis of MS was con rmed by the general practitioner. There were no exclusion criteria.,98.50746268656717
685,PRECIS-2,"Participants in the intervention group were contacted by telephone, by a health professional employed for the project, and an appointment was made to discuss self-care strategies relevant to each individual and to introduce the information booklet.",fulltext,"Participants in the intervention group were contacted by telephone, by a health professional employed for the project, and an appointment was made to discuss self-care strategies relevant to each individual and to introduce the information booklet.",100.0
686,PRECIS-2,"At the end of the visit, a summary of the multidisciplinary evaluation, along with the resulting therapeutic propositions, was discussed with the patient and caregivers.",fulltext,"ogist. At the end of the visit, a summary of the multidisciplinary evaluation, along with the resulting therapeutic propositions, was discussed with the patient and care",95.85798816568047
686,PRECIS-2,The primary outcome was the impact of the strategy on quality of life (QoL) measured using the MSIS-29 scale at inclusion and after six months.,fulltext,The primary outcome was the impact of the strategy on quality of life (QoL) measured using the MSIS-29 scale at inclusion and after six months.,100.0
686,PRECIS-2,"Two treatment strategies were compared: (i) an integrated multidisciplinary (IMD) approach, consisting of a half-day individually tailored comprehensive assessment in the MS clinic; and (ii) a standard care.",fulltext,"Two treatment strategies were compared: (i) an integrated multidisciplinary (IMD) approach, consisting of a half-day individually tailored comprehensive assessment in the MS clinic; and (ii) a standard care.",100.0
686,PRECIS-2,"The study protocol was approved by the coordinator of our local (Pitie´-Salpeˆtrie`re Hospital) ethics committee, and formal review by the committee was judged unnecessary.",fulltext,"roups. The study protocol was approved by the coordinator of our local (Pitie´-Salpeˆtrie`re Hospital) ethics committee, and formal review by the committee was judged unne",95.34883720930233
686,PRECIS-2,MS patients from the outpatient clinic of the Neurology Department of Pitie´-Salpeˆtrie`re Hospital were prospectively enrolled in the study between March 2010 and July 2012.,fulltext,MS patients from the outpatient clinic of the Neurology Department of Pitie´-Salpeˆtrie`re Hospital were prospectively enrolled in the study between March 2010 and July 2012.,100.0
686,PRECIS-2,"For patients in the IMD group, the multidisciplinary integrated outpatient clinic was planned at our MS clinic within a maximum three-month period after inclusion. These patients received a half-day (four to six hours) individually tailored assessment by the multidisciplinary group.",fulltext,"re 1). For patients in the IMD group, the multidisciplinary integrated outpatient clinic was planned at our MS clinic within a maximum three-month period after inclusion. These patients received a half-day (four to six hours) individually tailored assessment by the multidisciplinary",97.52650176678446
686,PRECIS-2,"Primary and secondary outcomes were assessed at inclusion, and after six (M6) and 12 (M12) months.",fulltext,"Primary and secondary outcomes were assessed at inclusion, and after six (M6) and 12 (M12) months.",100.0
686,PRECIS-2,"Inclusion criteria were: having MS (MacDonald criteria); being able to complete a questionnaire; and being in need for a multidisciplinary approach, defined by the requirement, in addition to the neurology specialist, of at least two different medical (rehabilitation specialist, neuro-urology specialist, psychiatrist) or allied health professionals (physiotherapist, occupational therapist, social worker, psychologist, and neuropsychologist). Patients who were not living independently in the community were excluded.",fulltext,"2012. Inclusion criteria were: having MS (MacDonald criteria); being able to complete a questionnaire; and being in need for a multidisciplinary approach, defined by the requirement, in addition to the neurology specialist, of at least two different medical (rehabilitation specialist, neurourology specialist, psychiatrist) or allied health professionals (physiotherapist, occupational therapist, social worker, psychologist, and neuropsychologist). Patients who were not living independently in the community were exc",98.65384615384616
686,PRECIS-2,"This is a prospective, randomized, controlled, monocentric clinical trial in MS patients.",fulltext,"This is a prospective, randomized, controlled, monocentric clinical trial in MS patients.",100.0
687,PRECIS-2,"Participants were contacted by the physiotherapist each week to discuss progress and update their exercise programme as appropriate by changing any combination of exercises, level of difficulty or number of repetitions.",fulltext,"Participants were contacted by the physiotherapist each week to discuss progress and update their exercise programme as appropriate by changing any combination of exercises, level of difficulty or number of repetitions.",100.0
687,PRECIS-2,Outcome measures were recorded at baseline and at the end of the intervention period (week 13).,fulltext,Outcome measures were recorded at baseline and at the end of the intervention period (week 13).,100.0
687,PRECIS-2,All outcome variables were analysed using repeated measures ANOVA models at the 5% level of significance.,fulltext,All outcome variables were analysed using repeated measures ANOVA models at the 5% level of significance.,100.0
687,PRECIS-2,"Letters were sent to 138 patients from the Multiple Sclerosis Service database, thought to be suitable for the study, inviting them to participate.",fulltext,"Letters were sent to 138 patients from the Multiple Sclerosis Service database, thought to be suitable for the study, inviting them to participate.",100.0
687,PRECIS-2,"To be included in the study participants were required to have a confirmed diagnosis of MS, an Expanded Disability Status Score of between 5 and 6.5, stable drug therapy for 30 days, no relapses in the previous three months, no significant co-morbidities such as coexisting cardiac or pulmonary condition and have access to the internet via personal or tablet computer.",fulltext,"To be included in the study participants were required to have a confirmed diagnosis of MS, an Expanded Disability Status Score of between 5 and 6.5, 13 stable drug therapy for 30 days, no relapses in the previous three months, no significant co-morbidities such as coexisting cardiac or pulmonary condition and have access to the internet via personal or tablet computer.",100.0
687,PRECIS-2,"The primary outcome measure, the timed 25ft walk, has good reliability and validity in the MS population.",fulltext,"The primary outcome measure, the timed 25 foot walk, 14 has good reliability and validity in the MS population.",100.0
687,PRECIS-2,"Participants were recruited from the Multiple Sclerosis Service, at the Douglas Grant Rehabilitation Centre, Irvine, Scotland.",fulltext,"Participants were recruited from the Multiple Sclerosis Service, at the Douglas Grant Rehabilitation Centre, Irvine, Scotland.",100.0
687,PRECIS-2,"The website (www.webbased-physio.com) consists of a home page, exercise pages and advice section. Each exercise page contains a video in half the screen, text explaining the exercise, an audio description of the exercise and a timer.",fulltext,"The website (www.webbasedphysio.com) consists of a home page, exercise pages and advice section. Each exercise page contains a video in half the screen, text explaining the exercise, an audio description of the exercise and a timer.",99.57081545064378
687,PRECIS-2,Participants were advised to undertake the exercise programme a minimum of twice a week and to complete their online exercise diary which was seen remotely by the physiotherapist.,fulltext,Participants were advised to undertake the exercise programme a minimum of twice a week and to complete their online exercise diary which was seen remotely by the physiotherapist.,100.0
688,PRECIS-2,A brief monitoring phone call once a month was used to obtain information about the patient’s medical visits and hospital admissions in the previous month.,fulltext,A brief monitoring phone call once a month was used to obtain information about the patient’s medical visits and hospital admissions in the previous month.,100.0
688,PRECIS-2,"At the end of a one year follow up period, all patients underwent the same comprehensive interview as at baseline.",fulltext,"At the end of a one year follow up period, all patients underwent the same comprehensive interview as at baseline.",100.0
688,PRECIS-2,"Patients were recruited from the multiple sclerosis centre of the neurological department of La Sapienza University, or from other institutional centres for multiple sclerosis in Rome.",fulltext,"Patients were recruited from the multiple sclerosis centre of the neurological department of La Sapienza University, or from other institutional centres for multiple sclerosis in Rome.",100.0
688,PRECIS-2,"The multidisciplinary team collaborated with the patient, physician, and caregiver in designing individualised clinical care and in coordinating home services as appropriate for the individual patient.",fulltext,"The multidisciplinary team collaborated with the patient, physician, and caregiver in designing individualised clinical care and in coordinating home services as appropriate for the individual patient.",100.0
688,PRECIS-2,"The primary analysis was an intention-to-treat analysis, including all randomised patients with at least one post-baseline assessment.",fulltext, the primary analysis after adjustment for baseline assessment,41.04477611940298
688,PRECIS-2,The study was conducted in Rome and was approved by the ethics committee of La Sapienza University.,fulltext,The study was conducted in Rome and was approved by the ethics committee of La Sapienza University.,100.0
688,PRECIS-2,"Secondary outcomes included changes in the Multiple Sclerosis Impact Scale (MSIS-29) physical and psychological subscales, the Multiple Sclerosis Walking Scale (MSWS-12), and the Multiple Sclerosis Quality of Life-54 (MSQOL-54) physical and mental health subscales.",fulltext,"f the cost of multiple sclerosis in the United States . Multiple Sclerosis 1998;4:419–25. 4 Parkin D, Jacoby A, McNamee P, et al. Treatment of multiple sclerosis with interferon beta: an appraisal of cost-effectiveness and quality of life. J",47.16981132075472
688,PRECIS-2,"The home based care multidisciplinary team included two neurologists, a urologist, a rehabilitation physiotherapist, a psychologist, a physical therapist, a nurse, a social worker, and a coordinator.",fulltext,"The home based care multidisciplinary team included two neurologists, a urologist, a rehabilitation physician, a psychologist, a physical therapist, a nurse, a social worker, and a coordinator.",95.47738693467338
688,PRECIS-2,Missing data were imputed using multiple imputation by chained equations.,fulltext,s were compared using ,24.65753424657534
688,PRECIS-2,The primary outcome was the change in the Expanded Disability Status Scale (EDSS) score from baseline to 12 months.,fulltext," was stratified by age and expanded disability status score (EDSS),",45.21739130434783
688,PRECIS-2,Patients randomised to routine hospital care were followed as usual in their multiple sclerosis referral centres.,fulltext,Patients randomised to routine hospital care were followed as usual in their multiple sclerosis referral centres.,100.0
688,PRECIS-2,"Based on individual needs, patients randomised to home based care were followed through home visits and telephone follow up.",fulltext,"Based on individual needs, patients randomised to home based care were followed through home visits and telephone follow up.",100.0
688,PRECIS-2,Eligible patients were assessed for suitability by the coordinator of the home based care team (LP).,fulltext,Eligible patients were assessed for suitability by the coordinator of the home based care team (LP).,100.0
688,PRECIS-2,The type of care was more than is normally available in the community through National Health Service care.,fulltext,The type of care was more than is normally available in the community through National Health Service care.,100.0
688,PRECIS-2,"Of the 297 consecutive patients screened, 201 were willing to participate in the study.",fulltext,"Of the 297 consecutive patients screened, 201 were willing to participate in the study.",100.0
689,PRECIS-2,Seven Multiple Sclerosis outpatient centres across Scotland.,fulltext,Seven Multiple Sclerosis outpatient centres across Scotland.,100.0
689,PRECIS-2,"Outcome measures were administered by two unblinded assessors at baseline (0), 3, 6, and 12 months, except for the Psychological Impact of Assistive Devices Score which was administered at 12 months only.",fulltext,"Outcome measures were administered by two unblinded assessors (Rebecca Hunter and A.L.) at baseline (0), 3, 6 and 12 months, except for the Psychological Impact of Assistive Devices Score 15 which was administered at 12 months only.",99.50980392156863
689,PRECIS-2,A Restricted Maximum Likelihood approach to fitting mixed models was employed to allow intention to treat assumptions to cope with missing data.,fulltext,A Restricted Maximum Likelihood approach to fitting mixed models was employed to allow intention to treat assumptions to cope with missing data.,100.0
689,PRECIS-2,"Participants required to have a clinical diagnosis of Multiple Sclerosis, persistent foot drop (lasting a minimum of three months) observed during a 5-minute walk test, stable disease (no change in the Extended Disability Status Score or relapse in previous three months), 5° of passive dorsiflexion and tolerance of functional electrical stimulation.",fulltext,"Participants required to have a clinical diagnosis of Multiple Sclerosis, persistent foot drop (lasting a minimum of three months) observed during a 5-minute walk test, stable disease (no change in the Extended Disability Status Score 12 or Renfrew et al. 3 relapse in previous three months), 5° of passive dorsiflexion and tolerance of functional electrical stimulation.",100.0
689,PRECIS-2,The primary outcome was walking speed as measured by the 5-minute self-selected walk test.,fulltext,The primary outcome was walking speed as measured by the 5-minute self-selected walk test.,100.0
689,PRECIS-2,"Potential participants were screened for eligibility, and written informed consent was gained prior to randomization.",fulltext,"Potential participants were screened for eligibility, and written informed consent was gained prior to randomization.",100.0
689,PRECIS-2,"Participants randomized to the usual care group were fitted with a custom-made, solid, ankle-foot orthosis by an orthotist, within four weeks of their initial assessment. The recommendations made by the Best Practice Statement for ankle-foot orthoses following stroke were applied.",fulltext,"Participants randomized to the usual care group were fitted with a custom-made, solid, ankle-foot orthosis by an orthotist, within four weeks of their initial assessment. The recommendations made by the Best Practice Statement for ankle-foot orthoses following stroke were applied.",100.0
689,PRECIS-2,Participants in both groups were instructed to gradually increase the wear of their devices over the first six weeks.,fulltext,Participants in both groups were instructed to gradually increase the wear of their devices over the first six weeks.,100.0
689,PRECIS-2,There were no specific measures to improve adherence to the interventions.,prompt,"herence, and measures to improve adherence ",51.35135135135135
690,PRECIS-2,"In this randomized, examiner-blind, controlled study, we recruited patients from three Italian centers.",fulltext,"In this randomized, examiner-blind, controlled study, we recruited patients from three Italian centers.",100.0
690,PRECIS-2,"All randomly assigned patients were included in the main intention-to-treat analysis, provided that at least one contact with the team occurred (HPA group).",fulltext,"All randomly assigned patients were included in the main intention-to-treat analysis, provided that at least one contact with the team occurred (HPA group).",100.0
690,PRECIS-2,"Dyads were randomly assigned (2:1) to receive HPA or UC. Allocation to treatment groups was done using a third-party, web-based computerized randomization procedure with stratified minimization for EDSS score (8.0–8.5, 9.0–9.5), presence of severe cognitive compromise (clinical judgment), and center (Online Supplementary Table 1).",fulltext,"Dyads were randomly assigned (2:1) to receive HPA or UC. Allocation to treatment groups was done using a third-party, web-based computerized randomization procedure with stratified minimization for EDSS score (8.0–8.5, 9.0–9.5), presence of severe cognitive compromise (clinical judgment), and center (Online Supplementary Table 1).",100.0
690,PRECIS-2,"A blind examiner assessed dyads at baseline, 3 months, and 6 months.",fulltext,"A blind examiner assessed dyads at baseline, 3 months, and 6 months.",100.0
690,PRECIS-2,"Participants were non-institutionalized adults (age ⩾ 18 years) with severe MS and their primary carers. Other patient inclusion criteria were primary or secondary progressive MS, Expanded Disability Status Scale (EDSS) score ⩾ 8.0, complex symptoms, and ⩾2 unmet care needs.",fulltext,"Participants were non-institutionalized adults (age ⩾ 18 years) with severe MS and their primary carers. Other patient inclusion criteria were primary or secondary progressive MS, 1,13 Expanded Disability Status Scale (EDSS) score ⩾ 8.0, 14 complex symptoms, 15 and ⩾2 unmet care needs.",100.0
690,PRECIS-2,"The pre-specified primary endpoints were changes in patient quality of life (SEIQoL-DW) and symptom burden (PC Outcome Scale-Symptoms-MS, POS-S-MS).",fulltext,"The pre-specified primary endpoints were changes in patient quality of life (SEIQoL-DW) and symptom burden (PC Outcome Scale-Symptoms-MS, POSS-MS).",99.32432432432432
690,PRECIS-2,"Based on the principles of PC, each center had a HPA team consisting of a physician (neurologist or physiatrist), a nurse (case manager and team leader), a psychologist, and a social worker. Nurses of the Milan and Rome centers had degrees and worked full time in PC; the Catania nurse attended a week-long individual training course.",fulltext,"Based on the principles of PC, 17 each center had a HPA team consisting of a physician (neurologist or physiatrist), a nurse (case manager and team leader), a psychologist, and a social worker. Nurses of the Milan and Rome centers had degrees and worked full time in PC; the Catania nurse attended a week-long individual training course.",100.0
690,PRECIS-2,"After a comprehensive assessment of the dyad needs based on direct observation and on visit 1 information (available via the eCRF), the HPA team defined the contents of the intervention, involving the dyad and the patient caring physician (the intervention was not intended to replace existing services). Subsequently, the team verified program implementation and reviewed it as necessary.",fulltext,"After a comprehensive assessment of the dyad needs based on direct observation and on visit 1 information (available via the eCRF), the HPA team defined the contents of the intervention, involving the dyad and the patient caring physician (the intervention was not intended to replace existing services). Subsequently, the team verified program implementation and reviewed it as necessary.",100.0
690,PRECIS-2,"The team was not on call for dyads: in the event of emergencies, dyads contacted the patient caring physician or emergency medical services.",fulltext,"The team was not on call for dyads: in the event of emergencies, dyads contacted the patient caring physician or emergency medical services.",100.0
691,PRECIS-2,"FACETS was delivered in hotel meeting-room facilities, with the exception of one centre, where it was held in a rehabilitation hospital.",fulltext,"FACETS was delivered in hotel meeting-room facilities, with the exception of one centre, where it was held in a rehabilitation hospital.",100.0
691,PRECIS-2,Facilitators were all qualified to a senior/advanced level (in the UK minimum of a Band 7 on the NHS Agenda for Change (AfC) grading structure). (17) Facilitators were trained to deliver the intervention at 1-day workshops and psychological advice and debriefing were available for facilitators throughout the trial.,fulltext,Facilitators were all qualified to a senior/advanced level (in the UK minimum of a Band 7 on the NHS Agenda for Change (AfC) grading structure). (17) Facilitators were trained to deliver the intervention at 1-day workshops and psychological advice and debriefing were available for facilitators throughout the trial.,100.0
691,PRECIS-2,"The main inclusion criteria were: (1) clinically definite MS diagnosis, (2) fatigue impacting on daily life (Fatigue Severity Scale total score >4) (16) and (3) ambulatory.",fulltext,"The main inclusion criteria were: (1) clinically definite MS diagnosis, (2) fatigue impacting on daily life (Fatigue Severity Scale total score >4) (16) and (3) ambulatory.",100.0
691,PRECIS-2,"Participants were recruited in three UK centres (Poole, Bristol, Southampton/Portsmouth) from primary or secondary care, or via MS Society newsletters/websites.",fulltext,"Participants were recruited in three UK centres (Poole, Bristol, Southampton/Portsmouth) from primary or secondary care, or via MS Society newsletters/websites.",100.0
691,PRECIS-2,The reasons for non-attendance are reported in figure 1.,fulltext,The reasons for non-attendance are reported in figure 1.,100.0
691,PRECIS-2,"All questionnaire outcomes were self-reported for both groups, presented in a booklet format with a large font and administered and returned through the post. This meant that participants could pace the completion of the outcome measures in their own homes.",fulltext,"All questionnaire outcomes were self-reported for both groups, presented in a booklet format with a large font and administered and returned through the post. This meant that participants could pace the completion of the outcome measures in their own homes.",100.0
691,PRECIS-2,"Primary outcomes were fatigue severity (Global Fatigue Severity (GFS) subscale of the Fatigue Assessment Instrument (FAI)), (18) disease-specific quality of life (QOL) (total score on the Multiple Sclerosis Impact Scale, V.1 (MSIS-29, V.1)) (19) and self-efficacy for managing fatigue (Multiple Sclerosis-Fatigue Self-Efficacy scale—adapted from the Control subscale of the MS Self-Efficacy scale). (20)",fulltext,"Primary outcome measures These were: (1) fatigue severity (Global Fatigue Severity (GFS) subscale of the Fatigue Assessment Instrument (FAI)), 18 (2) disease-specific quality of life (QOL) (total score on the Multiple Sclerosis Impact Scale, V.1 (MSIS-29, V.1)) 19 and (3) self-efficacy for managing fatigue (Multiple Sclerosis-Fatigue Self-Efficacy scale—adapted from the Control subscale of the MS Self-Efficacy scale). 20 ",99.0074441687345
691,PRECIS-2,"The intervention is highly structured. Each session follows the same general format, namely, facilitator-delivered presentations, flipchart discussions, group activities and homework.",fulltext,"The intervention is highly structured. Each session follows the same general format, namely, facilitator-delivered presentations, flipchart discussions, group activities and homework.",100.0
691,PRECIS-2,The main analysis was intention-to-treat but we also conducted a ‘per protocol’ analysis (excluding participants who attended fewer than four FACETS sessions).,fulltext,The main analysis was intention-to-treat but we also conducted a ‘per protocol’ analysis (excluding participants who attended fewer than four FACETS sessions).,100.0
692,PRECIS-2,"Participants were asked to listen to the prerecorded sessions and to follow the instructions (e.g., Breathing rhythm, number of steps during walking exercises, speed of execution of the movement). Participants also received a weekly telephone call lasted up to 15 min, during which a detailed report concerning the session(s) was reviewed and adapted if required.",fulltext,"Participants were asked to listen to the prerecorded sessions and to follow the instructions (e.g., Breathing rhythm, number of steps during walking exercises, speed of execution of the movement). Participants also received a weekly telephone call lasted up to 15 min, during which a detailed report concerning the session(s) was reviewed and adapted if required.",100.0
692,PRECIS-2,"Mobility, fatigue, and the impact of the disease on the patient’s life were measured.",fulltext,"Mobility, fatigue, and the impact of the disease on the patient’s life were measured.",100.0
692,PRECIS-2,"The Kruskal-Wallis test was used to analyze the homogeneity of groups in relation to sociodemographic characteristics. Second, comparisons between pre and post intervention were analyzed in each group using the Wilcoxon signed-ranked t-test for within-group differences, and effect sizes were given by the matched rank biserial correlation (Kerby, 2014), interpreted as Person’s r.",fulltext,"the Kruskal-Wallis test was used to analyze the homogeneity of groups in relation to sociodemographic characteristics. Second, comparisons between pre and post intervention were analyzed in each group using the Wilcoxon signed-ranked t-test for withingroup differences, and effect sizes were given by the matched rank biserial correlation (Kerby, 2014), interpreted as Person’s r.",99.73753280839895
692,PRECIS-2,"Mindfulness-Based Intervention group (MBI) (n = 12) received daily Mindfulness training in the form of prerecorded sessions (6 sessions of 10 minutes each equal to one hour/day) using TailorBuilder (TB) application, aiming at developing awareness of emotions and sensations. Mindfulness practice took place individually at home six times per week, without any assistance.",fulltext,"Mindfulness-Based Intervention group (MBI) (n = 12) received daily Mindfulness training in the form of prerecorded sessions (6 sessions of 10 minutes each equal to one hour/day) using TailorBuilder (TB) application, aiming at developing awareness of emotions and sensations. Mindfulness practice took place individually at home six times per week, without any assistance.",100.0
692,PRECIS-2,"Participants were recruited from two hospitals in the Parisian region, in France receiving outpatient services for MS at a regional medical center.",fulltext,"Participants were recruited from two hospitals in the Parisian region, in France receiving outpatient services for MS at a regional medical center.",100.0
692,PRECIS-2,"Two measurement times are carried out in pre-post intervention, at baseline and after eight weeks.",fulltext,"Two measurement times are carried out in pre-post intervention, at baseline and after eight weeks.",100.0
692,PRECIS-2,"This clinical and multicentric trial took place from July 2017 to January 2020, in two hospitals in the Parisian Region, France (Hospitals – CHI Poissy St Germain-en-Laye and R. Poincaré, Garches).",fulltext,"This clinical and multicentric trial took place from July 2017 to January 2020, in two hospitals in the Parisian Region, France (Hospitals – CHI Poissy St Germain-en-Laye and R. Poincaré, Garches).",100.0
692,PRECIS-2,"The procedures for this study were approved by research ethics committees (CPP) «Ile de France XI » (ID: 2016-A00537-44), authorized from The National Agency for the Safety of Medicines and Health (ASNM) and registered under the identification number ID: NCT03785483.",fulltext,"The procedures for this study were approved by research ethics committees (CPP) «Ile de France XI » (ID: 2016-A00537-44), authorized from The National Agency for the Safety of Medicines and Health (ASNM) and registered under the identification number ID: NCT03785483.",100.0
692,PRECIS-2,"Thirty-five adults were randomly assigned to one of the three groups: a Mindfulness-Based Intervention group (N = 12), Implementation Intention group (N = 11), and a Control Group (N = 12). All the groups received the same Physical Activity program. The Mindfulness condition group received daily training in the form of pre-recorded sessions while the Implementation group elaborated their specific plans once a week.",fulltext,"Thirty-five adults were randomly assigned to one of the three groups: a Mindfulness-Based Intervention group (N = 12), Implementation Intention group (N = 11), and a Control Group (N = 12). All the groups received the same Physical Activity program. The Mindfulness condition group received daily training in the form of prerecorded sessions while the Implementation group elaborated their specific plans once a week.",99.76076555023924
693,PRECIS-2,Both programs were held once a week for 10 weeks. Participants were asked to attend at least 9 out of 10 SC or yoga sessions.,fulltext,Both programs were held once a week for 10 weeks. Participants were asked to attend at least 9 out of 10 SC or yoga sessions.,100.0
693,PRECIS-2,"Twenty patients with relapsing–remitting MS, primary progressive MS or secondary progressive MS, aged 26–50 years, with an EDSS not more than 6 and EDSS pyramidal functions score (EDSSpyr) more than 2 were included in the prospective study.",fulltext,"usion. Twenty patients with relapsing–remitting MS, primary progressive MS or secondary progressive MS, aged 26–50 years, with an EDSS not more than 6 and EDSS pyramidal functions score (EDSSpyr) more than 2 were included in the prospective",97.08333333333333
693,PRECIS-2,Participants were randomized into SC or yoga group.,fulltext,study. Participants were randomized into SC or yoga,86.27450980392157
693,PRECIS-2,Participants were asked to attend at least 9 out of 10 SC or yoga sessions.,fulltext,Participants were asked to attend at least 9 out of 10 SC or yoga sessions.,100.0
693,PRECIS-2,"Data were analyzed by SPSS program for Windows, version 17.0. Wilcoxon signed ranks test was used to compare the difference before and after each program. Statistical significance was set at p ≤ 0.05.",fulltext,"alysis Data were analyzed by SPSS program for Windows ® , version 17.0. Wilcoxon signed ranks test was used to compare the difference before and after each program. Statistical significance was set at p ",96.5
693,PRECIS-2,"We evaluated spasticity, cognitive function, mood and fatigue before and after both programs, that lasted 10 weeks, with standardized assessment methods.",fulltext,"We evaluated spasticity, cognitive function, mood and fatigue before and after both programs, that lasted 10 weeks, with standardized assessment methods.",100.0
693,PRECIS-2,"SC took place in the Training, Occupation and Care Centre under the supervision of two SC instructors with a Slovenian Sports Climbing Committee License. The climbing wall with an inclination of 90◦ and the height of 5 m was adjusted for patients with physical disabilities by adding numerous and bigger holds. All patients were belayed with the “top rope” system, which provided a safe climbing opportunity with the possibility to rest in the wall at any point.",fulltext,"sions. SC took place in the Training, Occupation and Care Centre under the supervision of two SC instructors with a Slovenian Sports Climbing Committee License. The climbing wall with an inclination of 90 ◦ and the height of 5 m was adjusted for patients with physical disabilities by adding numerous and bigger holds. All patients were belayed with the “top rope” system, which provided a safe climbing opportunity with the possibility to rest in the wall at any",98.48484848484848
693,PRECIS-2,"Examinations were performed by the members of Multiple Scle-rosis Center at the Division of Neurology, University Medical Center Ljubljana.",fulltext,"ssment Examinations were performed by the members of Multiple Sclerosis Center at the Division of Neurology, University Medical Center Lju",94.24460431654677
693,PRECIS-2,"Hatha yoga took place in the facilities of Institute of Rehabilitation, Republic of Slovenia. The program was adjusted for MS patients and was held by a MS specialist nurse who is a yoga instructor with a license for patients with physical disabilities.",fulltext,"point. Hatha yoga took place in the facilities of Institute of Rehabilitation, Republic of Slovenia. The program was adjusted for MS patients and was held by a MS specialist nurse who is a yoga instructor with a license for patients with physical disabi",97.23320158102767
694,PRECIS-2,The primary endpoint was the change in the BBS (difference from BBS baseline to week 12).,fulltext,The primary endpoint was the change in the BBS 10–13 (difference from BBS baseline to week 12).,100.0
694,PRECIS-2,"Examinations and questionnaires were completed prior to the first hippotherapy session (baseline), after 6–7 weeks (interim assessment) and after 12 weeks (final assessment). Physiotherapists who assessed the endpoints in a separate room were blinded and explicitly trained not to question patients or hippotherapists. Patients were individually instructed to keep confidentiality of their allocation group.",fulltext,"Examinations and questionnaires were completed prior to the first hippotherapy session (baseline), after 6–7 weeks (interim assessment) and after 12 weeks (final assessment). Physiotherapists who assessed the endpoints in a separate room were blinded and explicitly trained not to question patients or hippotherapists. Patients were individually instructed to keep confidentiality of their allocation group.",100.0
694,PRECIS-2,"The study was conducted at five sites in Germany, all of which have hippotherapy experience as stipulated by the rules of the German Consortium for Therapeutic Riding.",fulltext,"The study was conducted at five sites in Germany, all of which have hippotherapy experience as stipulated by the rules of the German Consortium for Therapeutic Riding.",100.0
694,PRECIS-2,Eligible patients were randomized to one of the two groups using sealed opaque envelopes on the basis of a computer-generated randomization list.,fulltext,Eligible patients were randomized to one of the two groups using sealed opaque envelopes on the basis of a computer-generated randomization list.,100.0
694,PRECIS-2,"Analyses were based on the modified intention-to-treat set (modified ITT). This set encompasses all randomized patients with valid baseline assessment. The primary endpoint change of BBS from baseline to 12 weeks was calculated using an analysis of covariance (ANCOVA) with the fixed effects group, center, age, gender, EDSS classification, and baseline BBS (type 2 sums of squares). Missing values were imputed through the last observation carried forward (LOCF) value.",fulltext," Analyses were based on the modified intention-totreat set (modified ITT). This set encompasses all randomized patients with valid baseline assessment. The primary endpoint change of BBS from baseline to 12 weeks was calculated using an analysis of covariance (ANCOVA) with the fixed effects group, center, age, gender, EDSS classification, and baseline BBS (type 2 sums of squares). Missing values were imputed through the last observation carried forward (LOCF) value",99.57446808510639
694,PRECIS-2,"MS patients older than 18 years who had a confirmed MS with spasticity of the lower limbs and an Expanded Disability Status Scale (EDSS) score between 4 and 6.5 were eligible for inclusion. Patients who had received hippotherapy within the last 12 months, a body weight over 90 kg, no balance while sitting, and acute exacerbation during the 4-week period before start of the therapy were excluded.",fulltext,"MS patients older than 18 years who had a confirmed MS with spasticity of the lower limbs and an Expanded Disability Status Scale (EDSS) 9 score between 4 and 6.5 were eligible for inclusion. Patients who had received hippotherapy within the last 12 months, a body weight over 90 kg, no balance while sitting, and acute exacerbation during the 4-week period before start of the therapy were excluded.",100.0
694,PRECIS-2,"Examinations and questionnaires were completed prior to the first hippotherapy session (baseline), after 6–7 weeks (interim assessment) and after 12 weeks (final assessment).",fulltext,"Examinations and questionnaires were completed prior to the first hippotherapy session (baseline), after 6–7 weeks (interim assessment) and after 12 weeks (final assessment).",100.0
694,PRECIS-2,"Patients in the pilot study by Sager et al. (one-arm trial, 16 patients) showed an average improvement of 5.6 points on the Berg Balance Scale (BBS) by week 12. The pilot study by Schneider et al. (randomized crossover trial, 12 patients) showed an average improvement of 6.5 points on BBS after 6 weeks of hippotherapy.",fulltext,"Patients in the pilot study by Sager et al. (one-arm trial, 16 patients) showed an average improvement of 5.6 points on the Berg Balance Scale (BBS) by week 12. The pilot study by Schneider et al. (randomized crossover trial, 12 patients) showed an average improvement of 6.5 points on BBS after 6 weeks of hippotherapy.",100.0
694,PRECIS-2,"Patients of the intervention group received hippotherapy (as defined by the regulations for hippotherapy of the Deutsches Kuratorium für Therapeutisches Reiten e.V. (DKThR)) once a week for 12 weeks as an add-on therapy to their standard care, which remained unchanged.",fulltext,"Patients of the intervention group received hippotherapy (as defined by the regulations for hippotherapy of the Deutsches Kuratorium für Therapeutisches Reiten e.V. (DKThR)) 8 once a week for 12 weeks as an addon therapy to their standard care, which remained unchanged.",99.62825278810409
695,PRECIS-2,"Participants whose clinical features appeared incompatible with the recorded diagnosis were excluded, as were those with neurological complications of primarily non-neurological conditions such as diabetes mellitus, or additional causes of severe disability.",fulltext,"Participants whose clinical features appeared incompatible with the recorded diagnosis were excluded, as were those with neurological complications of primarily non-neurological conditions such as diabetes mellitus, or additional causes of severe disability.",100.0
695,PRECIS-2,An occupational therapist (OT) then visited EG participants to provide education and information and to discuss a personalized 12-month health action plan.,fulltext,An occupational therapist (OT) then visited EG participants to provide education and information and to discuss a personalized 12-month health action plan.,100.0
695,PRECIS-2,For binary outcomes univariate and multivariate logistic regression were performed. Analyses were performed both with and without adjustment for baseline rates of events in the groups.,fulltext,For binary outcomes univariate and multivariate logistic regression were performed. Analyses were performed both with and without adjustment for baseline rates of events in the groups.,100.0
695,PRECIS-2,"In the education group (EG), baseline data were reviewed by an expert panel which advised on actions most likely to promote each individual's physical, social and psychological well-being.",fulltext,"In the education group (EG), baseline data were reviewed by an expert panel which advised on actions most likely to promote each individual's physical, social and psychological well-being.",100.0
695,PRECIS-2,Setting: Participants' homes in the City of Nottingham.,fulltext,Setting: Participants' homes in the City of Nottingham.,100.0
695,PRECIS-2,Participants were assessed at baseline and 12 months later.,fulltext,Participants were assessed at baseline and 12 months later.,100.0
695,PRECIS-2,"From July 1998 we approached the 177 GPs based within the City of Nottingham boundaries (population 282,000).",fulltext,From July 1998 we approached the 177 GPs based within the City of Nottingham boundaries (population 282000). ,99.08256880733946
695,PRECIS-2,We searched practice diagnostic lists and prescription records and made intensive enquiries for additional patients from individual GPs.,fulltext,We searched practice diagnostic lists and prescription records and made intensive enquiries for additional patients from individual GPs.,100.0
695,PRECIS-2,"In order to preserve a focus on primarily physical disabilities, dementing disorders such as Alzheimer's disease were not included.",fulltext,"In order to preserve a focus on primarily physical disabilities, dementing disorders such as Alzheimer's disease were not included.",100.0
695,PRECIS-2,"To avoid ascertainment bias towards people already receiving specific health or social services, we used GP information as the sole method for identifying potential participants.",fulltext,"To avoid ascertainment bias towards people already receiving specific health or social services, we used GP information as the sole method for identifying potential participants.",100.0
695,PRECIS-2,"Within six weeks of the baseline visit, participants in the EG received an education visit from the research OT, who provided personalized advice and information based on the expert panel discussion, a tailored version of the standard information package, and a specially constructed leaflet offering information about the participant's condition and about self-help organizations.",fulltext,"Within six weeks of the baseline visit, participants in the EG received an education visit from the research OT, who provided personalized advice and information based on the expert panel discussion, a tailored version of the standard information package, and a specially constructed leaflet offering information about the participant's condition and about self-help organizations.",100.0
695,PRECIS-2,"EG participants received a single follow-through phone call from the research OT to confirm and reinforce the educational content of the visit, after which EG patients had no subsequent contact with the OT.",fulltext,"EG participants received a single follow-through phone call from the research OT to confirm and reinforce the educational content of the visit, after which EG patients had no subsequent contact with the OT ",100.0
695,PRECIS-2,Primary outcome measures were reports of one or more falls or skin sores.,fulltext,Primary outcome measures were reports of one or more falls or skin sores.,100.0
695,PRECIS-2,"Participants eligible for inclusion were adults aged over 15 years with one of the following possible recorded diagnoses: MS, PD and other causes of progressive parkinsonism, motor neurone disease, Huntington's disease and other degenerative disorders affecting the central nervous system, muscles or peripheral nerves.",fulltext,"Participants eligible for inclusion were adults aged over 15 years with one of the following possible recorded diagnoses: MS, PD and other causes of progressive parkinsonism, motor neurone disease, Huntington's disease and other degenerative disorders affecting the central nervous system, muscles or peripheral nerves.",100.0
696,PRECIS-2,Patients in both groups may have received additional optional treatment with intravenous myethylprednisolone (IVMP) in the first 6 months post-natalizumab discontinuation.,fulltext,Patients in both groups may have received additional optional treatment with intravenous myethylprednisolone (IVMP) in the first 6 months post-natalizumab discontinuation.,100.0
696,PRECIS-2,Both groups initiated another DMT in a similar manner.,fulltext,Both groups initiated another DMT in a similar manner.,100.0
696,PRECIS-2,"IDG: Patients who discontinued natalizumab therapy at once and initiated another DMT (interferon, GA therapy or an oral DMT-fingolimod, dimethyl fumatate or teriflunomide) at 1–6 months following the last natalizumab infusion.",fulltext,"IDG: Patients who discontinued natalizumab therapy at once and initiated another DMT (interferon, GA therapy or an oral DMTfingolimod, dimethyl fumatate or teriflunomide) at 1–6 months following the last natalizumab infusion ",99.5575221238938
696,PRECIS-2,Participants who satisfied the inclusion criteria were randomised at baseline (week 0) to either the IDG or the TG according to a concealed computer-generated randomisation schedule.,fulltext,Participants who satisfied the inclusion criteria were randomised at baseline (week 0) to either the IDG or the TG according to a concealed computer-generated randomisation schedule.,100.0
696,PRECIS-2,"This was a prospective, phase IV, 12-month, open-label, single center single-blinded (MRI) randomised study.",fulltext,"This was a prospective, phase IV, 12-month, open-label, single center single-blinded (MRI) randomised study.",100.0
696,PRECIS-2,"Standardised MRI was performed at baseline, 6 and 12 months from the last natalizumab infusion.",fulltext,"Standardised MRI was performed at baseline, 6 and 12 months from the last natalizumab infusion.",100.0
696,PRECIS-2,The primary objective of this study was to compare two modes of natalizumab cessation interventions: immediate discontinuation group (IDG) versus a TG approach as measured by serial MRI and number of relapses during a 12-month period in patients treated with natalizumab for at least 24 months.,fulltext,The primary objective of this study was to compare two modes of natalizumab cessation interventions: immediate discontinuation group (IDG) versus a TG approach as measured by serial MRI and number of relapses during a 12-month period in patients treated with natalizumab for at least 24 months.,100.0
696,PRECIS-2,Fifty relapsing patients with multiple sclerosis (MS) who had been on natalizumab therapy ≥24 months and were contemplating natalizumab discontinuation were enrolled.,fulltext,Fifty relapsing patients with multiple sclerosis (MS) who had been on natalizumab therapy ≥24 months and were contemplating natalizumab discontinuation were enrolled.,100.0
696,PRECIS-2,"Statistical analyses were carried out using IBM SPSS Statistics 22 (IBM Corp, Armonk, New York, USA).",fulltext,"Statistical analyses were carried out using IBM SPSS Statistics 22 (IBM Corp, Armonk, New York, USA).",100.0
697,PRECIS-2,Setting: Community center-based and home-based exercise program.,fulltext,Setting: Community center-based and home-based exercise program.,100.0
697,PRECIS-2,Community dwelling people with MS were recruited through the Multiple Sclerosis Society of New South Wales and South Australia.,fulltext,Community dwelling people with MS were recruited through the Multiple Sclerosis Society of New South Wales and South Australia.,100.0
697,PRECIS-2,"Inclusion criteria were the following: diagnosis of MS made by a neurologist, able to walk 10 meters with or without an aid within 2 minutes, no relapse of their MS in the past 4 weeks, and no other neurological or orthopedic condition that would affect their function.",fulltext,"Inclusion criteria were the following: diagnosis of MS made by a neurologist, able to walk 10 meters with or without an aid within 2 minutes, no relapse of their MS in the past 4 weeks, and no other ",73.97769516728626
697,PRECIS-2,Data were analyzed according to the intention-to-treat principle.,fulltext, Data were analyzed according to the intention-totreat principle,96.92307692307692
697,PRECIS-2,The center- and home-based groups completed an 8-week progressive functional and balance training exercise program. The center-based groups of four to six were supervised by a physiotherapist. The home-based group was provided with telephone support.,fulltext,The center- and home-based groups completed an 8-week progressive functional and balance training exercise program. The center-based groups of four to six were supervised by a physiotherapist. The home-based group was provided with telephone support.,100.0
697,PRECIS-2,The primary outcome was gait speed (10-meter walk test).,fulltext,The primary outcome was gait speed (10-meter walk test).,100.0
697,PRECIS-2,"Participants in both groups were encouraged to maintain their usual activity levels and engagement in any other exercise throughout the trial, with any variation self-reported to the treating physiotherapist.",fulltext,"Participants in both groups were encouraged to maintain their usual activity levels and engagement in any other exercise throughout the trial, with any variation self-reported to the treating physiotherapist.",100.0
697,PRECIS-2,"Outcome assessments were conducted at baseline, immediately post-intervention and at 8-week follow-up.",fulltext,"Outcome assessments were conducted at baseline, immediately postintervention and at 8-week follow-up.",99.01960784313727
697,PRECIS-2,"Exercises were aimed at improving gait speed, endurance, and balance. They were individualized, specific, progressed in load, and performed at a moderate to high intensity.",fulltext,"Exercises were aimed at improving gait speed, endurance, and balance. They were individualized, specific, progressed in load, and performed at a moderate to high intensity.",100.0
705,PRECIS-2,Follow-up occurred at 12 wk (both groups) and 12 months (intervention group only to explore the sustainability of long-term change).,fulltext,Follow-up occurred at 12 wk (both groups) and 12 months (intervention group only to explore the sustainability of long-term change).,100.0
705,PRECIS-2,We analyzed outcome data to examine the potential effectiveness of the Hockey FIT program on the basis of an intent-to-treat approach.,fulltext,We analyzed outcome data to examine the potential effectiveness of the Hockey FIT program on the basis of an intent-to-treat approach.,100.0
705,PRECIS-2,The planned primary outcome for the definitive trial was the difference between groups in mean weight loss (kg) and percentage weight change from baseline to 12 wk.,fulltext,The planned primary outcome for the definitive trial was the difference between groups in mean weight loss (kg) and percentage weight change from baseline to 12 wk.,100.0
705,PRECIS-2,"We used a pragmatic approach for the program venue at each site, using a combination of the hockey team’s arena and an affiliated health club facility.",fulltext,"We used a pragmatic approach for the program venue at each site, using a combination of the hockey team_s arena and an affiliated health club facility.",99.33774834437085
705,PRECIS-2,"There were 10 men in the intervention group who were classified as ‘‘noncompleters’’ (i.e., attended G50% of sessions including none in the final 6 wk), but this did not preclude them from attending follow-up measurement sessions.",fulltext,"There were 10 men in the intervention group who were classified as ‘‘noncompleters’’ (i.e., attended G50% of sessions including none in the final 6 wk), but this did not preclude them from attending follow-up measurement sessions.",100.0
705,PRECIS-2,"Eligible participants were male 35–65 yr old with a BMI of Q28 kgIm^(−2) and met PA safety requirements (i.e., no risk indicated by the Physical Activity Readiness Questionnaire [36] or clearance from a health care provider).",fulltext,"Eligible participants were male 35–65 yr old with a BMI of Q28 kgIm j2 and met PA safety requirements (i.e., no risk indicated by the Physical Activity Readiness Questionnaire [36] or clearance from a health care provider).",98.66666666666667
705,PRECIS-2,"Program sessions comprised the following: 1) classroom-based teaching of behavior change techniques and simple information sharing on PA and healthy eating, delivered to encourage participant interaction and mutual learning, and 2) exercise sessions where men performed aerobic, strength, and flexibility exercises, incorporating their passion for hockey off the ice.",fulltext,"Program sessions comprised the following: 1) classroom-based teaching of behavior change techniques and simple information sharing on PA and healthy eating, delivered to encourage participant interaction and mutual learning, and 2) exercise sessions where men performed aerobic, strength, and flexibility exercises, incorporating their passion for hockey off the ice.",100.0
705,PRECIS-2,"Sessions were designed to appeal to men; they included elements of friendly competition and encouraged banter, humor, and peer support.",fulltext,"Sessions were designed to appeal to men; they included elements of friendly competition and encouraged banter, humor, and peer support.",100.0
705,PRECIS-2,"Recruitment occurred using a variety of methods (e.g., hockey team e-mail blasts and social media accounts, study website, posters, traditional media advertisements, word of mouth, direct contact at team arena).",fulltext,"Recruitment occurred using a variety of methods (e.g., hockey team e-mail blasts and social media accounts, study Web site (http://hockeyfansintraining.org/), posters, traditional media advertisements, word of mouth, direct contact at team arena).",100.0
712,PRECIS-2,"The pregnant women in labor obtained normal obstetrical treatment. Where the study was carried out, the following was permitted: the presence of someone to accompany the pregnant lady, the use of methods other than drugs such as taking a shower, massages in the lower back region and breathing exercises as well as liberty of movement (in cases where this did not go against medical advice).",fulltext,"The pregnant women in labor obtained normal obstetrical treatment. Where the study was carried out, the following was permitted: the presence of someone to accompany the pregnant lady, the use of methods other than drugs such as taking a shower, massages in the lower back region and breathing exercises as well as liberty of movement (in cases where this did not go against medical advice).",100.0
712,PRECIS-2,"The VAS was used and reused immediately after the treatment (VAS20) and 60 minutes after the treatment, once consent had been given by the pregnant women in labor to participate in the study.",fulltext,"The VAS was used and reused immediately after the treatment (VAS20) and 60 minutes after the treatment, once consent had been given by the pregnant women in labor to participate in the study.",100.0
712,PRECIS-2,"The pregnant women in labor were allocated through a sequential list of random numbers in blocks of six patients generated using the program Excel® and they were distributed in three groups: acupressure (SP6), touch group (TG)/placebo and the control group (CG).",fulltext,"The pregnant women in labor were allocated through a sequential list of random numbers in blocks of six patients generated using the program Excel® and they were distributed in three groups: acupressure (SP6), touch group (TG)/placebo and the control ",95.80152671755725
712,PRECIS-2,"The averages for the pain measured using the VAS were not different for the three groups that were a part of the study (p-value=0.0929), however they were less in the acupressure groups immediately after receiving the treatment (p-value=<0.0001). This was also the case where the treatment lasted for 1 hour (p-value=0.0001). This was the case in comparison with placebo and control groups.",fulltext,"The averages for the pain measured using the VAS were not different for the three groups that were a part of the study (p-value=0.0929), however they were less in the acupressure groups immediately after receiving the treatment (p-value=<0.0001). This was also the case where the treatment lasted for 1 hour (p-value=0.0001). This was the case in comparison with placebo and control groups.",100.0
712,PRECIS-2,"The SP6 group with the pregnant women in labor received deep pressure (± 5kg) with fast decompression applied to their thumbs which did not bring about any discomfort. The TG group received a superficial touch that was of very low intensity (± 100g). In both groups, the contact was at the SP6 bilateral point, during the contractions, in one period of 20 minutes.",fulltext,"The SP6 group with the pregnant women in labor received deep pressure (± 5kg) with fast decompression applied to their thumbs which did not bring about any discomfort. The TG group received a superficial touch that was of very low intensity (± 100g) (15) . In both groups the contact was at the SP6 bilateral point, during the contractions, in one period of 20 minutes.",99.72527472527473
712,PRECIS-2,"The study was carried out between January and August of 2013. The subjects were pregnant women admitted to a teaching tertiary public hospital on the outskirts of the state of Sao Paulo, Brazil.",fulltext," was carried out between January and August of 2013. The subjects were pregnant women admitted to a teaching tertiary public hospital on the outskirts of the state of Sao Paulo, Brazil.",95.36082474226804
712,PRECIS-2,"The pregnant women were randomly divided into three groups at a university hospital in the suburbs of Sao Paulo, Brazil, in order to receive either acupressure treatment, a placebo or participate as part of a control group.",fulltext,"The pregnant women were randomly divided into three groups at a university hospital in the suburbs of Sao Paulo, Brazil, in order to receive either acupressure treatment, a placebo or participate as part of a control group.",100.0
712,PRECIS-2,The Kruskal-Wallis test was used to make comparisons between the groups in relation to quantitative variables. The Mann-Whitney test was used in cases where significant differences were found for multiple comparisons. The Chi-squared test was used in relation to the association between groups and variables categories. The Exact Fisher test was used in cases where there were at least 20% of the expected values being less than five.,fulltext,The Kruskal-Wallis test was used to make comparisons between the groups in relation to quantitative variables. The Mann-Whitney test was used in cases where significant differences were found for multiple comparisons. The Chi-squared test was used in relation to the association between groups and variables categories. The Exact Fisher test was used in cases where there were at least 20% of the expected values being less than five.,100.0
712,PRECIS-2,The researcher that was responsible for applying the acupressure went through 32 hours’ worth of training.,fulltext,The researcher that was responsible for applying the acupressure went through 32 hours’ worth of training.,100.0
713,PRECIS-2,The aim of this study was to evaluate the effectiveness of a partnership-based self-management programme for patients with mild and moderate COPD.,fulltext,The aim of this study was to evaluate the effectiveness of a partnership-based self-management programme for patients with mild and moderate COPD.,100.0
713,PRECIS-2,"Patients in the experimental group did not have better health-related quality of life, less anxiety or depression, increased physical activity, fewer exacerbations or better smoking status than patients in the control group.",fulltext,"Patients in the experimental group did not have better health-related quality of life, less anxiety or depression, increased physical activity, fewer exacerbations or better smoking status than patients in the control group.",100.0
713,PRECIS-2,The group (intervention) 9 time interaction from a repeated analysis of variance was used to measure whether or not the effect of intervention was statistically significant for variables that followed an approximately normal distribution.,fulltext,The group (intervention) 9 time interaction from a repeated analysis of variance was used to measure whether or not the effect of intervention was statistically significant for variables that followed an approximately normal distribution ,100.0
713,PRECIS-2,"The theoretical framework, Partnership with people with COPD and their families, was the basis for this intervention.",fulltext,"The theoretical framework, Partnership with people with COPD and their families (Ingadottir & Jonsdottir 2010, Jonsdottir & Ingadottir 2011a,b), was the basis for this intervention.",100.0
713,PRECIS-2,"Patients, 45-65 years old, with mild and moderate chronic obstructive pulmonary disease were invited with a family member.",fulltext,"Patients, 45-65 years old, with mild and moderate chronic obstructive pulmonary disease were invited with a family member.",100.0
713,PRECIS-2,"Data were collected at baseline and at month 12. Additionally, data collection was carried out in the experimental group at month 6 after the last treatment session.",fulltext,"Data were collected at baseline and at month 12. Additionally, data collection was carried out in the experimental group at month 6 after the last treatment session.",100.0
713,PRECIS-2,The treatment site was a clinical research centre located on a university-hospital campus.,fulltext,The treatment site was a clinical research centre located on a university-hospital campus.,100.0
713,PRECIS-2,Patients were recruited from each of the primary health care centres and lung physicians’ offices.,fulltext,Patients were recruited from each of the primary health care centres and lung physicians’ offices.,100.0
713,PRECIS-2,The intervention was provided for 6 months with a subsequent follow-up for additional 6 months.,fulltext,The intervention was provided for 6 months with a subsequent follow-up for additional 6 months.,100.0
714,PRECIS-2,"An 80% power, at the 5% significance level (two tailed test), of detecting a 20% difference in the proportion of patients reviewed from 30% to 50% required 206 patients.",fulltext,"An 80% power, at the 5% significance level (two tailed test), of detecting a 20% difference in the proportion of patients reviewed ",77.51479289940828
714,PRECIS-2,We wrote to all eligible patients inviting them to take part in the study.,fulltext,We wrote to all eligible patients inviting them to take part in the study.,100.0
714,PRECIS-2,Patients were free to arrange any consultations they wished.,fulltext,Patients were free to arrange any consultations they wished.,100.0
714,PRECIS-2,"Primary outcome measures were the proportion of patients reviewed within three months of randomisation and change in asthma related quality of life, as measured by the Juniper mini asthma quality of life questionnaire.",fulltext,"Primary outcome measures were the proportion of patients reviewed within three months of randomisation and change in asthma related quality of life, as measured by the Juniper mini asthma quality of life questionnaire.",100.0
714,PRECIS-2,Nurses were told to make up to four attempts to contact the patient by phone.,fulltext,Nurses were told to make up to four attempts to contact the patient by phone.,100.0
714,PRECIS-2,Nurses arranged any follow-up consultations (whether in the surgery or by telephone) they deemed clinically necessary.,fulltext,Nurses arranged any follow-up consultations (whether in the surgery or by telephone) they deemed clinically necessary.,100.0
714,PRECIS-2,"Patients were excluded if the diagnosis of asthma had been made within the previous year, if they had chronic obstructive pulmonary disease, if communication difficulties made a telephone consultation impossible, or (at the general practitioner’s request) for major social or medical reasons.",fulltext,"Patients were excluded if the diagnosis of asthma had been made within the previous year, if they had chronic obstructive pulmonary disease, if communication difficulties made a telephone consultation impossible, or (at the general practitioner’s request) for major social or medical reasons.",100.0
714,PRECIS-2,From their computerised asthma registers the practices identified adults (>18 years) who had asked for a bronchodilator inhaler prescription in the previous six months but who had not had a routine asthma review in the preceding 11 months.,fulltext,From their computerised asthma registers the practices identified adults (>18 years) who had asked for a bronchodilator inhaler prescription in the previDepartment,67.36401673640167
714,PRECIS-2,Nurses were given no instructions about the content of the review except that it should reflect their normal practice and be appropriate to each patient’s clinical need.,fulltext,Nurses were given no instructions about the content of the review except that it should reflect their normal practice and be appropriate to each patient’s clinical need.,100.0
714,PRECIS-2,Four general practices in England.,fulltext,Four general practices in England.,100.0
715,PRECIS-2,"After gaining patient consent, demographics and disease activity score in 28 joints (DAS28), patients were randomly assigned using a remote secure telephone randomisation service provided by Leeds University Clinical Trials Research Unit.",fulltext,"After gaining patient consent, demographics and disease activity score in 28 joints (DAS28), patients were randomly assigned using a remote secure telephone randomisation service provided by Leeds University Clinical Trials Research Unit.",100.0
715,PRECIS-2,"The primary outcome was DAS28 and secondary outcomes were pain severity (pain-VAS), fatigue (fatigue-VAS) and duration of morning stiffness measured at each study visit. Other secondary outcome measures were at baseline, weeks 26 and 52: RA quality of life; health assessment questionnaire disability index; hospital anxiety and depression scale; arthritis self-efficacy scale; and Leeds satisfaction questionnaire.",fulltext,"The primary outcome was DAS28 and secondary outcomes were pain severity (pain-VAS), fatigue (fatigue-VAS) and duration of morning stiffness measured at each study visit. Other secondary outcome measures were at baseline, weeks 26 and 52: RA quality of life; 31 health assessment questionnaire disability index; 32 hospital anxiety and depression scale; 33 arthritis self-efficacy scale; 34 and Leeds satisfaction questionnaire ",100.0
715,PRECIS-2,"The primary outcome was DAS28 and secondary outcomes were pain severity (pain-VAS), fatigue (fatigue-VAS) and duration of morning stiffness measured at each study visit.",fulltext,"The primary outcome was DAS28 and secondary outcomes were pain severity (pain-VAS), fatigue (fatigue-VAS) and duration of morning stiffness measured at each study visit.",100.0
715,PRECIS-2,"The NLC interventions usually include allocated 30-min time slots in which the CNS takes history, performs physical examination, pain control, prescribing or recommending medication and dosage changes, intra-articular or intramuscular steroid injections, provision of patient education, psychosocial support and ordering blood tests or X-rays. Referrals for ward admission, to the rheumatologist or other health professionals, were carried out as appropriate.",fulltext,"The NLC interventions usually include allocated 30-min time slots in which the CNS takes history, performs physical examination, pain control, prescribing or recommending medication and dosage changes, intra-articular or intramuscular steroid injections, provision of patient education, psychosocial support and ordering blood tests or X-rays. Referrals for ward admission, to the rheumatologist or other health professionals, were carried out as appropriate.",100.0
715,PRECIS-2,"This study required three practitioners at each centre; a CNS, a rheumatologist and a blind independent assessor. Nine CNS and 10 rheumatologists delivered the interventions. The CNS had a median experience of 10 years in their current post while the rheumatologists had a median of 9 years at consultant level.",fulltext,"This study required three practitioners at each centre; a CNS, a rheumatologist and a blind independent assessor. Nine CNS and 10 rheumatologists delivered the interventions. The CNS had a median experience of 10 years in their current post while the rheumatologists had a median of 9 years at consultant level.",100.0
715,PRECIS-2,The study was conducted in outpatient clinics of 10 rheumatology centres across the UK.,fulltext,The study was conducted in outpatient clinics of 10 rheumatology centres across the UK.,100.0
715,PRECIS-2,"The inclusion criteria were: a positive diagnosis of RA (1987 American College of Rheumatology (ACR) criteria), age 18 years or older and the ability to complete questionnaires unaided. Exclusions were: unstabilised concomitant disease, awaiting surgery and already receiving care from the practitioners involved in the study.",fulltext,"The inclusion criteria were: a positive diagnosis of RA (1987 American College of Rheumatology (ACR) criteria), 29 age 18 years or older and the ability to complete questionnaires unaided. Exclusions were: unstabilised concomitant disease, awaiting surgery and already receiving care from the practitioners involved in the study.",100.0
715,PRECIS-2,"NLC had longer consultations (median 20 min, IQR=15–30 vs RLC, 15, 10–15), made fewer medication and dosage changes; ordered fewer intra-articular and intramuscular steroid injections and requested fewer radiological investigations than RLC. There was little difference in the ordering of non-protocol bloods or referrals to other health professionals. NLC provided patient education and psychosocial support more frequently than RLC, and CNS conferred more with the rheumatologist than vice versa.",fulltext," min. NLC had longer consultations (median 20 min, IQR=15–30 vs RLC, 15, 10–15), made fewer medication and dosage changes; ordered fewer intra-articular and intramuscular steroid injections and requested fewer radiological investigations than RLC. There was little difference in the ordering of non-protocol bloods or referrals to other health professionals. NLC provided patient education and psychosocial support more frequently than RLC, an",87.75100401606426
715,PRECIS-2,"Analysis of the primary endpoint (average ΔDAS28) and other endpoint comparisons was carried out using linear regression modelling adjusting for age, gender, centre and baseline DAS28 score. Estimates for secondary health outcome measures included additional adjustment for corresponding baseline value. For the ΔDAS28, p values were generated that tested against the null hypothesis of a between-group difference of 0.6 in favour of RLC.",fulltext,"30 Analysis of the primary endpoint (average ΔDAS28) and other endpoint comparisons was carried out using linear regression modelling adjusting for age, gender, centre and baseline DAS28 score. Estimates for secondary health outcome measures included additional adjustment for corresponding baseline value. For the ΔDAS28, p values were generated that tested against the null hypothesis of a between-group difference of 0.6 in favour of",98.85844748858447
722,PRECIS-2,A total of 623 participants were randomized from 33 centres (12 Aboriginal Medical Services) between January 2010 and May 2012.,fulltext,A total of 623 participants were randomized from 33 centres (12 Aboriginal Medical Services) between 9,79.52755905511812
722,PRECIS-2,"Participants randomized to the ‘polypill-based strategy’ received a polypill containing aspirin 75 mg, simvastatin 40 mg, lisinopril 10 mg and either atenolol 50 mg or hydrochlorothiazide 12.5 mg. Participants randomized to ‘usual care’ continued with separate medications and doses as prescribed by their doctor.",fulltext,"Participants randomized to the ‘polypill-based strategy’ received a polypill containing aspirin 75 mg, simvastatin 40 mg, lisinopril 10 mg and either atenolol 50 mg or hydrochlorothiazide 12.5 mg. Participants randomized to ‘usual care’ continued with separate medications and doses as prescribed by their doctor.",100.0
722,PRECIS-2,"Self-reported use of all medications was assessed at each visit, recorded as the number of days on which medication was taken in the immediately preceding week.",fulltext,"Self-reported use of all medications was assessed at each visit, recorded as the number of days on which medication was taken in the immediately preceding week.",100.0
722,PRECIS-2,"Primary outcomes were self-reported use of indicated combination treatment (antiplatelet, statin and 2 BP lowering drugs for 4 of the previous seven days) at study end; and changes in systolic BP and total cholesterol from baseline to study end.",fulltext,"Primary outcomes were self-reported use of indicated combination treatment (antiplatelet, statin and 2 BP lowering therapies for 4 of the previous seven days) at study end; and changes in systolic BP and total cholesterol from baseline to study end.",98.78542510121457
722,PRECIS-2,"The doctor could, at any time, change prescription to the alternative polypill version, add drugs on top of the polypill, or withdraw the polypill and substitute individual drugs of their choice.",fulltext,"The doctor could, at any time, change prescription to the alternative polypill version, add drugs on top of the polypill, or withdraw the polypill and substitute individual drugs of their choice.",100.0
722,PRECIS-2,"Participants attended the primary healthcare centres for trial assessments at randomization and 12 month intervals thereafter. All participants were also reviewed one month post-randomization and at intervening six month intervals, but these could be conducted by telephone.",fulltext,"Participants attended the primary healthcare centres for trial assessments at randomization and 12 month intervals thereafter. All participants were also reviewed one month post-randomization and at intervening six month intervals, but these could be conducted by telephone.",100.0
722,PRECIS-2,All analyses were conducted on an intention-to-treat basis without imputation of missing data.,fulltext,All analyses were conducted on an intention-to-treat basis without imputation of missing data.,100.0
722,PRECIS-2,"No attempt was made to influence the management of usual care participants. Those allocated to the polypill-based strategy were prescribed one of the polypill versions at the discretion of their doctor, to be taken at a time suggested by the doctor.",fulltext,"No attempt was made to influence the management of usual care participants. Those allocated to the polypill-based strategy were prescribed one of the polypill versions at the discretion of their doctor, to be taken at a time suggested by the doctor.",100.0
722,PRECIS-2,"All patient care was provided through existing primary healthcare practices, with rural and remote communities included to ensure that ‘real-life’ variations in healthcare delivery were captured.",fulltext,"All patient care was provided through existing primary healthcare practices, with rural and remote communities included to ensure that ‘real-life’ variations in healthcare delivery were captured.",100.0
725,PRECIS-2,"It was emphasized that good standards of care, both surgical and nonsurgical, should be provided throughout the treatment pathway for the injury, including surgical care or management of the sling, postoperative care, and rehabilitation in both groups.",fulltext,"It was emphasized that good standards of care, both surgical and nonsurgical, should be provided throughout the treatment pathway for the injury, including surgical care or management of the sling, postoperative care, and rehabilitation in both groups.",100.0
725,PRECIS-2,"Of 125 patients allocated to the surgical group, 109 (87%) received surgery and 16 (13%) were treated nonsurgically.",fulltext,"Of 125 patients allocated to the surgical group, 109 (87%) received surgery and 16 (13%) were treated nonsurgically.",100.0
725,PRECIS-2,All analyses were on an intention-to-treat basis and included all randomized patients in the groups to which they were randomized.,fulltext,All analyses were on an intention-to-treat basis and included all randomized patients in the groups to which they were randomized.,100.0
725,PRECIS-2,"Valid OSS responses were recorded for 232 patients (93%) at 6 months, 225 (90%) at 12 months, and 215 (86%) at 24 months.",fulltext,"Valid OSS responses were recorded for 232 patients (93%) at 6 months, 225 (90%) at 12 months, and 215 (86%) at 24 months.",100.0
725,PRECIS-2,Participating hospitals did not introduce new or experimental interventions for these fractures during the study.,fulltext,Participating hospitals did not introduce new or experimental interventions for these fractures during the study.,100.0
725,PRECIS-2,Patients received their allocated treatment from the recruiting hospital.,fulltext,Patients received their allocated treatment from the recruiting hospital.,100.0
725,PRECIS-2,Patients were eligible for inclusion if they were aged 16 years or older and presented within 3 weeks after sustaining a displaced fracture of the proximal humerus that involved the surgical neck.,fulltext,Patients were eligible for inclusion if they were aged 16 years or older and presented within 3 weeks after sustaining a displaced fracture of the proximal humerus that involved the surgical neck.,100.0
725,PRECIS-2,"The primary outcome was the Oxford Shoulder Score (OSS), which is a shoulder-specific outcome measure validated in a UK population.",fulltext,"The primary outcome was the Oxford Shoulder Score (OSS), which is a shoulder-specific outcome measure validated in a UK population.",100.0
725,PRECIS-2,"The PROFHER collaborators recruited patients for this pragmatic, open, multicenter, parallel-group, superiority, randomized clinical trial between September 2008 and April 2011 from orthopedic departments (fracture clinics or wards) at 32 acute UK National Health Service hospitals.",fulltext,"The PROFHER collaborators recruited patients for this pragmatic, open, multicenter, parallel-group, superiority, randomized clinical trial between September 2008 and April 2011 from orthopedic departments (fracture clinics or wards) at 32 acute UK National Health Service hospitals.",100.0
733,PRECIS-2,"Adherence was defined as (minutes spent exercising/intended minutes) 100%, where patients with values exceeding 75% were regarded as ‘adherent’.",fulltext,"Adherence was defined as (minutes spent exercising/intended minutes) 100%, where patients with values exceeding 75% were regarded as ‘adherent’.",100.0
733,PRECIS-2,"Practices were recruited with assistance from Primary Care Research Networks for London, Derby, and Nottingham.",fulltext,"Practices were recruited with assistance from Primary Care Research Networks for London, Derby, and Nottingham.",100.0
733,PRECIS-2,Analyses were undertaken without researchers being blind to the treatment arm allocation.,fulltext,Analyses were undertaken without researchers being blind to the treatment arm allocation.,100.0
733,PRECIS-2,Patients aged ≥65 years were identified by searches of computerised medical records and invited to participate by letter from their GP.,fulltext,Patients aged ≥65 years were identified by searches of computerised medical records and invited to participate by letter from their GP.,100.0
733,PRECIS-2,"The FaME intervention took place in a group once a week and included exercises to be carried out at home, unsupervised, twice weekly. The OEP was undertaken at home, unsupervised, and comprised exercises to be done three times per week.",fulltext,"The FaME intervention took place in a group once a week and included exercises to be carried out at home, unsupervised, twice weekly. The OEP was undertaken at home, unsupervised, and comprised exercises to be done three times per week.",100.0
733,PRECIS-2,The primary outcome was the proportion of participants who reported reaching ≥150 minutes of MVPA per week.,fulltext,The primary outcome was the proportion of participants who reported reaching ≥150 minutes of MVPA per week.,100.0
733,PRECIS-2,Participants in the usual-care arm were not offered either programme.,fulltext,Participants in the usual-care arm were not offered either programme.,100.0
733,PRECIS-2,] independently mobile (with or without a walking aid); and [,fulltext,] independently mobile (with or without a walking aid); and [,100.0
733,PRECIS-2,Both interventions were delivered for 24 weeks.,fulltext,Both interventions were delivered for 24 weeks.,100.0
733,PRECIS-2,"The OEP — ankle weights and hand holds; and FaME — resistance bands and hand holds, plus a move to more dynamic balance work and floor work with postural stability instructors.",fulltext," OEP — ankle weights and hand holds; and • FaME — resistance bands and hand holds, plus a move to more dynamic balance work and floor work with postural stability instructors.",98.29545454545455
733,PRECIS-2,"Volunteer peer mentors supported participants in the OEP arm, and weekly FaME classes were run in local venues by postural stability instructors trained to work with older people.",fulltext,"Volunteer peer mentors supported participants in the OEP arm, and weekly FaME classes were run in local venues by postural stability instructors trained to work with older people.",100.0
733,PRECIS-2,] physically able to take part in group exercise.,fulltext,] physically able to take part in group exercise.,100.0
733,PRECIS-2,"Participants were analysed in the groups to which they were randomised, regardless of whether they received the intervention or not, and multiple imputation was used to include all participants in the analyses.",fulltext,"Participants were analysed in the groups to which they were randomised, regardless of whether they received the intervention or not, and multiple imputation was used to include all participants in the analyses.",100.0
733,PRECIS-2,The primary time point was chosen as 12 months post-intervention to match other trials.,fulltext,The primary time point was chosen as 12 months postintervention to match other trials.,98.85057471264368
733,PRECIS-2,"Attempts were made to exclude those who were already exercising at, or above, the target level through a pre-assessment screening telephone call.",fulltext,"Attempts were made to exclude those who were already exercising at, or above, the target level through a pre-assessment screening telephone call.",100.0
733,PRECIS-2,"Participants were followed up every 6 months after the end of the intervention period, until 24 months.",fulltext,"Participants were followed up every 6 months after the end of the intervention period, until 24 months.",100.0
733,PRECIS-2,Patients were eligible to participate if they were: [,fulltext,Patients were eligible to participate if they were: [,100.0
733,PRECIS-2,"The interventions were the home-based Otago Exercise Program (OEP), and a group-based exercise programme called Falls Management Exercise (FaME).",fulltext," Otago Exercise Programme (OEP), 10 and a group-based exercise programme called Falls Management Exercise (FaME).",74.48275862068965
733,PRECIS-2,"Secondary outcomes included falls, quality of life, balance confidence, and costs.",fulltext,"Secondary outcomes included falls, quality of life, balance confidence, and costs.",100.0
